Podcasts about scientific advisory committee

Back in 2024, the BMJ revealed how more than half of the members of the UK government's Scientific Advisory Committee on Nutrition, had declared financial interests with food and drinks companies. A tightening of the rules followed, but two years after our initial investigation, we have returned - and we found that nearly a third of nutrition advisors still have significant ties to the food industry. Chris Van Tulleken, professor of infection and immunology at University College London, and author of the book “Ultra Processed People”, joins us to explain why he thinks ongoing industry ties are bad for the UK's health.   Also this week. We have tight regulation of medical tech in the UK, but new AI tools don't fit neatly into that existing process - and so the government has set up a National Commission on the Regulation of AI in Healthcare,  Alastair Denniston, and Henrietta Hughes, who headed that commission, join us to explain how AI should be monitored, how we can ensure it's safety, and who should be responsible when something goes wrong.   Reading list: A third of UK government's nutrition advisers are still paid by food industry, including Coca Cola and Nestlé National Commission into the Regulation of AI in Healthcare: Recommendations for a future regulatory framework

Want to hear the latest on psoriasis research? We've got just the expert. This week, we're joined by Dr. Wilson Liao as he as he explores emerging science, clinical challenges, and integrative care strategies to bridge the gap between research and practice in psoriasis management. Dr. Wilson Liao is Professor of Dermatology and Director of the Psoriasis Center at the University of California San Francisco. Dr. Liao is a dermatologist with expertise in biologic therapy and phototherapy and human geneticist who has contributed to the identification of over 60 psoriasis susceptibility genes. He has led numerous genetic, transcriptomic, proteomic, and microbiome studies in psoriasis. Dr. Liao's group has also investigated the impact of environmental factors on psoriasis, including diet, stress, exercise, sleep, and pollution. He currently serves as a member of the National Psoriasis Foundation Medical Board and Scientific Advisory Committee.  Learning Objectives: a) Summarize key advances in psoriasis immunopathogenesis and targeted therapies. b) Apply evidence-based approaches to integrating emerging treatments and integrative care in clinical practice. c) Identify strategies for comorbidity management and patient-centered communication Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. To learn more about Psoriasis, visit LearnSkin.com to enroll in the  Advancing Clinician Competence in Psoriasis and Psoriatic Arthritis Management: Emerging Immune Pathways and Integrative Care. In collaboration with the National Psoriasis Foundation and supported by independent educational grants from AbbVie, Johnson & Johnson, Ortho Dermatologics, Sun Pharmaceutical Industries, Inc, Takeda Pharmaceuticals U.S.A., Inc and UCB

Last Friday, the 5th Circuit Court of Appeals blocked a ruling from the FDA that allowed the medication abortion drug mifepristone to be sent to patients without an in-person visit to a healthcare provider. Shortly after, the Supreme Court issued a temporary stay, allowing the drug to continue to be distributed for a short period of time.Kelcie Moseley-Morris has been covering this story for the Louisiana Illuminator and Stateline. She joins us with the latest.According to new population data released by the U.S. Census Bureau, New Orleans and the surrounding communities are continuing to decline in population. Since 2020, the 7-parish metro area has decreased by more than 36,000 residents. In the meantime, the Baton Rouge area has seen a slight uptick in residents.Allison Plyer, chief demographer at the Data Center and former chair of the U.S. Census Bureau's Scientific Advisory Committee, joins us with more.Martha Reeves, the legendary Motown voice, Rock and Roll Hall of Fame inductee and lead singer of Martha and the Vandellas, is coming to New Orleans. The singer known for the hit songs “Dancing in the Street” and “Heatwave” will headline a one–night event at the New Orleans Jazz and Blues Market tonight (May 6). Dubbed, “Come and Get These Memories,” the event will feature Reeves discussing behind-the-scenes stories about some of the most iconic musicians and songs in Motown history. Martha Reeves joined Louisiana Considered's managing producer — and longtime fan — Alana Schreiber with more. —Today's episode of Louisiana Considered was hosted by Adam Vos. Our managing producer is Alana Schreiber. We get production support from Garrett Pittman and our assistant producer, Aubry Procell.You can listen to Louisiana Considered Monday through Friday at noon and 7 p.m. It's available on Spotify, the NPR App and wherever you get your podcasts. Louisiana Considered wants to hear from you!Please fill out our pitch line to let us know what kinds of story ideas you have for our show. And while you're at it, fill out our listener survey! We want to keep bringing you the kinds of conversations you'd like to listen to.Louisiana Considered is made possible with support from our listeners. Thank you!

The new 2025–2030 U.S. Dietary Guidelines have ignited controversy, and for once, nutrition policy is trending. From an upside-down food pyramid stacked with red meat, butter, and full-fat dairy to confusing messaging on saturated fat, processed foods, and plant-based diets, many experts are asking: How did we get here?In this episode, we're joined by Dr. Matthew Nagra, Canadian naturopathic doctor, nutrition researcher, and science communicator, to break down what actually happened behind the scenes. We unpack the disconnect between the 20-member Scientific Advisory Committee and the nine-person review panel, the role of ideology and industry ties, and why the final visuals contradict the written recommendations.We cover:Why the inverted food pyramid is misleading (and possibly unworkable)The saturated fat contradiction, and what the evidence really saysRed meat, cancer risk, and what the guidelines leave outThe problematic treatment of vegan and plant-based dietsDairy recommendations, lactose intolerance, and equity concernsUltra-processed foods, breakfast cereals, and nuance lost in translationWhy institutions may ignore the pyramid, but the public won'tIf you're confused by the headlines, frustrated by the visuals, or worried about how these guidelines could influence schools, policy, and public perception, this conversation brings clarity, context, and evidence, without the spin.Please subscribe and drop us a review—your feedback helps fellow noobs find their way to better nutrition.Have a question for Michelle? Get in touch at n4noobs@gmail.com or on Facebook at https://www.facebook.com/nutritionfornoobs.Dr Matthew Nagra can be found here:Website: https://drmatthewnagra.com/ https://www.instagram.com/dr.matthewnagrahttps://www.youtube.com/@dr.matthewnagrahttps://www.tiktok.com/@dr.matthewnagrahttps://www.facebook.com/dr.matthewnagra

In this episode, we are joined by Dr. Charles Hillman, a Professor in the Department of Psychology and the Department of Physical Therapy, Movement, and Rehabilitation Sciences at Northeastern University in Boston, Massachusetts. Dr. Hillman is also the co-director of the Center for Cognitive and Brain Health, which focuses on understanding how lifestyle choices and behaviors impact brain health and cognition. Throughout his career, Dr. Hillman has published over 300 articles and co-edited a text on Functional Neuroimaging in Exercise and Sport Sciences. He has also served on numerous committees, including the Institute of Medicine of the National Academies and the Health and Human Services Physical Activity Guidelines for American's Scientific Advisory Committee. In this conversation, we delve into Dr. Hillman's research on how lifestyle choices such as physical activity and diet impact brain health and cognitive function. We also discuss the mission of the Center for Cognitive and Brain Health and its research on how to maximize health and well-being and promote effective functioning for individuals across the lifespan. Join us as we explore the fascinating research of Dr. Charles Hillman and his team at the Center for Cognitive and Brain Health. -------- This podcast episode is sponsored by Fibion Inc. | Better Sleep, Sedentary Behaviour and Physical Activity Research with Less Hassle --- Collect, store and manage SB and PA data easily and remotely - Discover ground-breaking Fibion SENS --- SB and PA measurements, analysis, and feedback made easy.  Learn more about Fibion Research --- Learn more about Fibion Sleep and Fibion Circadian Rhythm Solutions. --- Fibion Kids - Activity tracking designed for children. --- Collect self-report physical activity data easily and cost-effectively with Mimove. --- Explore our Wearables,  Experience sampling method (ESM), Sleep,  Heart rate variability (HRV), Sedentary Behavior and Physical Activity article collections for insights on related articles. --- Refer to our article "Physical Activity and Sedentary Behavior Measurements" for an exploration of active and sedentary lifestyle assessment methods. --- Learn about actigraphy in our guide: Exploring Actigraphy in Scientific Research: A Comprehensive Guide. --- Gain foundational ESM insights with "Introduction to Experience Sampling Method (ESM)" for a comprehensive overview. --- Explore accelerometer use in health research with our article "Measuring Physical Activity and Sedentary Behavior with Accelerometers ". --- For an introduction to the fundamental aspects of HRV, consider revisiting our Ultimate Guide to Heart Rate Variability. --- Follow the podcast on Twitter https://twitter.com/PA_Researcher Follow host Dr Olli Tikkanen on Twitter https://twitter.com/ollitikkanen Follow Fibion on Twitter https://twitter.com/fibion https://www.youtube.com/@PA_Researcher

In this episode, we are joined by Dr. Charles Hillman, a Professor in the Department of Psychology and the Department of Physical Therapy, Movement, and Rehabilitation Sciences at Northeastern University in Boston, Massachusetts. Dr. Hillman is also the co-director of the Center for Cognitive and Brain Health, which focuses on understanding how lifestyle choices and behaviors impact brain health and cognition. Throughout his career, Dr. Hillman has published over 300 articles and co-edited a text on Functional Neuroimaging in Exercise and Sport Sciences. He has also served on numerous committees, including the Institute of Medicine of the National Academies and the Health and Human Services Physical Activity Guidelines for American's Scientific Advisory Committee. In this conversation, we delve into Dr. Hillman's research on how lifestyle choices such as physical activity and diet impact brain health and cognitive function. We also discuss the mission of the Center for Cognitive and Brain Health and its research on how to maximize health and well-being and promote effective functioning for individuals across the lifespan. Join us as we explore the fascinating research of Dr. Charles Hillman and his team at the Center for Cognitive and Brain Health. ----------- This podcast episode is sponsored by Fibion Inc. | Better Sleep, Sedentary Behaviour and Physical Activity Research with Less Hassle --- Collect, store and manage SB and PA data easily and remotely - Discover ground-breaking Fibion SENS --- SB and PA measurements, analysis, and feedback made easy.  Learn more about Fibion Research --- Learn more about Fibion Sleep and Fibion Circadian Rhythm Solutions. --- Fibion Kids - Activity tracking designed for children. --- Collect self-report physical activity data easily and cost-effectively with Mimove. --- Explore our Wearables,  Experience sampling method (ESM), Sleep,  Heart rate variability (HRV), Sedentary Behavior and Physical Activity article collections for insights on related articles. --- Refer to our article "Physical Activity and Sedentary Behavior Measurements" for an exploration of active and sedentary lifestyle assessment methods. --- Learn about actigraphy in our guide: Exploring Actigraphy in Scientific Research: A Comprehensive Guide. --- Gain foundational ESM insights with "Introduction to Experience Sampling Method (ESM)" for a comprehensive overview. --- Explore accelerometer use in health research with our article "Measuring Physical Activity and Sedentary Behavior with Accelerometers ". --- For an introduction to the fundamental aspects of HRV, consider revisiting our Ultimate Guide to Heart Rate Variability. --- Follow the podcast on Twitter https://twitter.com/PA_Researcher Follow host Dr Olli Tikkanen on Twitter https://twitter.com/ollitikkanen Follow Fibion on Twitter https://twitter.com/fibion https://www.youtube.com/@PA_Researcher

Episode Description:  Not sure if you should receive a vaccine given your psoriasis or psoriatic arthritis medication?  Dermatologist Dr. Jason Hawkes explores this question along with vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis. Listen as hosts Jeff Brown and LB Herbert discuss key questions about vaccine use and psoriatic disease with dermatologist and NPF Medical Board member Dr. Jason Hawkes who is co-owner, Chief Scientific Officer, and investigator with the Oregon Medical Research Center. Hear what the difference is between live and non-live vaccines, how type of vaccine and immunosuppressive medications impact the timing of vaccines in relation to treatment half-lives. Get your questions answered. The intent of this episode is to offer answers to questions about vaccine use for people with psoriasis and psoriatic arthritis who take immunosuppressive treatments.   Timestamps: (0:23) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Jason Hawkes. (1:15) In general, what is a vaccine and how it works in the body. (2:08) Will vaccines provide the same level of protection in people with psoriatic disease who are         on treatments that influence the immune system. (4:53) The difference between live and non-live vaccines.   (8:57) Summary of NPF Vaccine Recommendations in relation to live and non-live vaccines and             specific medications for psoriatic disease, including a definition of medication half-lives. (13:38) Vaccines that may be recommended prior to starting a systemic medication or biologic. (18:27) The mRNA vaccine – how it works in comparison to other vaccines. (22:31) How long immunity lasts from childhood vaccines. (25:24) The vaccine guidelines apply to both psoriasis and psoriatic arthritis with some nuances.      (28:38) Which healthcare provider to turn to for advice about vaccines and why. (31:54) Questions to ask your health care provider about vaccines. (33:26) How clinical trials and registries are evolving to assess the effect of vaccines with specific             medications and the need for greater understanding. (36:44) Develop a good relationship with your health care provider and don't be afraid to ask                 questions about your psoriatic disease, vaccines, or specific medications. Key Takeaways: ·       Vaccines work to help protect the body or stimulate protection against common infections or pathogens. There are different types that can be classified as either live or non-live vaccines.   ·       Evidence-based vaccine recommendations are available for people with psoriasis and psoriatic arthritis to help guide timing of when to receive live and non-live vaccines when taking immunosuppressive oral systemic medications and/or biologics.   ·       It's important to discuss which vaccines to consider, and how current psoriasis medication could impact the intended response and timing  with your health care team which includes a primary care physician, a dermatologist, and/or rheumatologist.    Guest Bio: Dermatologist Jason Hawkes, M.D., MS is Co-owner, Chief Scientific Officer and Investigator with Oregon Medical Research Center (OMRC) in Portland, Oregon. He is also a Clinical Assistant Professor of Dermatology at Oregon Health and Science University and the President and Sole Member of Hawkes Dermatology. Prior to joining the Oregon Medical Research Center, Dr. Hawkes held academic faculty appointments in the Departments of Dermatology at the University of Utah School of Medicine, Icahn School of Medicine at Mount Sinai, and University of California-Davis. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, chronic urticaria (hives), and eczema. He has a special interest in translational human research and the development of novel biologics and small molecules used for the treatment of inflammatory conditions. Dr. Hawkes is also a Councilor of the International Psoriasis Council (IPC) and serves on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF) where he participates in the development of clinical consensus statements. Resources:         “Does Having Psoriatic Disease Impact Vaccine Choices?” Psound Bytes™ podcast with Dr. Sandy Chat (University of California) and Dr. Christoph Ellebrecht (Dept. of Dermatology, University of Pennsylvania).       Medical Board Clinical Statements                

In this new episode, Dr. Lauren focuses on the diagnostic odyssey of getting a genetic diagnosis with Drs. Ame Shillington and Sheldon Garrison. Dr. Shillington is a clinical geneticist and assistant professor from Cincinnati Children's Hospital Medical Center. Dr. Garrison is Research Scientist at Rogers Behavioral Health who is on our Scientific Advisory Committee. Did You Know!? The average delay from initial concern to genetic diagnosis of rare disorders like Phelan-McDermid syndrome is over 9 years!Of individuals who receive a genetic diagnosis due to neurodevelopmental concerns, approximately 90% see improvement in their treatment management and care after receiving the diagnosis! Tune in to hear more about the research behind the delayed diagnosis of rare genetic disorders like Phelan-McDermid syndrome, and what each is doing to help reduce this delay and increase access to genetic testing! Check out the papers mentioned in the podcast below to learn more: Dr. Sheldon Garrison: https://pubmed.ncbi.nlm.nih.gov/40750893/ https://pubmed.ncbi.nlm.nih.gov/40252994/Dr. Ame Shillington: https://pubmed.ncbi.nlm.nih.gov/37642312/ https://pubmed.ncbi.nlm.nih.gov/35769998/

Dr Bec Sheean is the Director of Research and Programs at FightMND, leading strategy across all funded research and initiatives to accelerate progress against Motor Neurone Disease.With a PhD in neuroscience and a Graduate Certificate in Clinical Research, she champions collaborative, translational science. Bec chairs the International Research Director Forum, co-chairs the MND Research Collective, and serves on the International Alliance's Scientific Advisory Committee.This is Bec's first ever in-depth interview.+++ To support this podcast, check out our some of our sponsors & get discounts:→ $1,000 off Vanta: Your compliance superpower — vanta.com/high→ Get up to 6 months of Notion's Business plan for free with Notion AI included (worth $12K): Go to - https://ntn.so/highflyers & click “Apply Now”If you're keen to discuss sponsorship and partnering with us or recommend future guests, email us at contact@curiositycentre.com today!  ***CLICK HERE to read show notes from this conversation. Please enjoy!***Follow us on Instagram, LinkedIn or TwitterGet in touch with our Founder and Host, Vidit Agarwal directly hereContact us via our website to discuss sponsorship opportunities, recommend future guests or share feedback, we love hearing how to improve! Thank you for rating / reviewing this podcast on Apple Podcasts and Spotify, it helps others find us and convince guests to come on the show! ***The High Flyers Podcast is described as a "meticulously researched biography" that uncovers the untold stories of remarkable people and companies -- redefining the "high flyer". Launched in 2020, we have ranked in the global top ten podcasts for past two years, with listeners in 27 countries and over 200 episodes released. Excerpts of the podcast have been featured in Forbes, AFR, Daily Telegraph, and showcased at SXSW.200+ guests have joined host, Vidit Agarwal on the show from 15+ countries, including The CEO's of multi-billion dollar companies like Bunnings, Australia Post, Woolworths, Airwallex, Eucalyptus etc; Board Members at Macquarie Bank, ANZ, Reserve Bank etc; Former Prime Minister of Australia; Globally renowned Tech CEO's from Google, Microsoft, Xero etc, Successful Venture Capital and Family Office Investors; CIO's at the world's biggest superannuation funds; Leading Entertainers; Olympic Gold Medal Winning Athletes and interesting minds you wouldn't have heard of that are changing the world. Our parent company, Curiosity Center is your on-demand intelligence hub for knowledge, connections and growth to achieve your potential, everyday. Join 200,000+ Investors, Founders, Functional Leaders, CEOs and Emerging Leaders. Learn with the world's best and be 1% better everyday at https://curiositycentre.com***   

Nearly half of the global agriculture market is controlled by four companies. This level of concentration - driven by decades of mergers and poor regulation - has allowed agribusiness “titans” to dominate the farming sector.  Alasdair talks to Dr Jennifer Clapp, author of a new book about corporate domination of the farm sector and why it matters. Alasdair and Jennifer discuss how and why mass-merging has led to market distortions and high prices, and what solutions could improve the state of the sector.  Dr. Jennifer Clapp is a Professor at the School of Environment, Resources and Sustainability at the University of Waterloo, Canada. She is a member of the International Panel of Experts on Sustainable Food Systems and the Scientific Advisory Committee of the UN Food Systems Coordination Hub.  Click here to read our investigation into the UK biomass supply chain, or watch a clip from the BBC Newsnight documentary.

How big is too big? When it comes to corporate concentration many observers raise concerns about the tech industry. However, in the new book, Titans of Industrial Agriculture: how a few giant corporations came to dominate the farm sector and why it matters, political economist Jennifer Clapp draws attention to the overwhelming shadow a small handful of transnational corporations cast over the global agricultural sector. Professor Clapp argues that these corporations hold concentrated power over the agricultural sector that keep industrial agricultural practices entrenched in patterns of production, despite the concerns of the social, ecological and health impacts to society. She explains how we got to this point and what it might take to make changes. Jennifer's work at the intersection of the global economy, food security, and food systems, and the natural environment, looks specifically at issues of global governance. She is currently a member of the International Panel of Experts on Sustainable Food Systems, and a member of the Scientific Advisory Committee of the UN Food Systems Coordination Hub.  Interview Summary Norbert - Jennifer, let's just jump right in and I'd love for you to help our listeners understand a little bit more about your book. You write about corporate concentration in the agricultural input sector. Can you explain what this involves and what products are we really talking about?    Yes. The book is about what we call the agricultural inputs industry. And that's really four different product types typically, and maybe a fifth that we can talk about. So, one of them is farm machinery, and that's really referring to things like plows and tractors, harvesters, etc. That kind of machinery on the farm. The second industry is the fertilizer industry, which is all about, you know, the nutrients that we bring to the soil through fertilizer products like nitrogen, phosphorus, and potash. And the seed industry. That's another industry that is a key input for farmers. And then also pesticides. And when we talk about pesticides, we're referring to things like insecticides, chemicals that kill insects, but also chemicals that kill weeds and fungus. And so those are the four sort of big inputs that I talk about in the book. But also, the book covers a fifth input, an emerging input, which is data. And this is, especially as we're seeing the datafication and digitalization of farming. Increasingly data has now become a commodity that is bought and sold as an input into farming. Norbert - Great. I have to ask, what drew you to the input industry? I mean, let's be honest, that's not the thing that most people get excited about. Why should we be concerned? Yeah, that's a great question. I've actually had a very long interest in the seed in chemical industry. That goes way back to the start of my career because I did studies in agriculture for my PhD dissertation. But then I got quite interested in toxic waste and then that sort of drew me to this question of the global pesticide trade. And when I learned that, you know, oftentimes, like in the US there might be a banning of a pesticide that's no longer in use. But it was still being traded globally. And this, I found this very fascinating and how that industry worked. And that kind of drew me into understanding the connections between seeds and chemicals. And then when the digitalization of farming came along and in recent decades it became really clear that it wasn't just chemical and seed industry involved in that digitalization. It was also the fertilizer and the farm machinery sector. It made me want to understand the interconnections between these industries. I know it's like, maybe a bit specific, but they have huge consequences in terms of the way our food systems look like. And so that really drew me to understand where did these inputs come from? And why are they controlled by just a few large companies? Erika - Jennifer, I want to ask you a question about why this sector, especially related to the inputs, is so important when we're talking about food systems. And especially their social and ecological dimensions. And specifically in the book, you tease out many of the social and ecological costs of inputs such as pesticides. Also the social and ecological consequences of even farm machinery. So it would be great if you could elaborate on their importance.  Thanks, Erika. That's a great question and that's part of the reason why I was really drawn to study these inputs. Because I'm in a school of environmental studies, I'm very interested in these interconnections between food systems and environmental outcomes. I was really interested in learning more about where these industries came from, and as I was teasing out where they came from. And how they became dominated by such large companies, I also learned in much more depth about the ecological consequences of these inputs. I can just say a little bit about some of them because these consequences are so big that we almost forget to talk about them. They become embedded in the product itself. And so, one example is farm machinery. Farm machinery was originally seen as quite revolutionary and that it allowed farmers to harvest their fields much more quickly than they used to be able to before. But that also meant then that to make the equipment efficient and pay for them they might as well extend the size of their farm. And as farmers extended the size of their farm, in the US anyway, they moved west and displaced its indigenous people from the land, in terms of taking that land for farm production. But also, as farms began to consolidate and get larger, as mechanization continued, it also displaced others from the land. Poor farmers, black farmers, those who were renting land and didn't have access to their own. And so, people who were marginalized and we still considered marginalized in society today, were really being displaced from the land as a direct consequence of farm machinery. It's not that farm machinery is like necessarily something that we want to do away with today, but I think we need to recognize those historical connections. And really understand that when, you know, you see a book for a small child about farming and there might be a picture of a farmer and it's usually a white guy sitting on a tractor. We can forget that image has a lot of baggage associated with it in terms of displacement and inequality. And I think we need to recognize that. But it does not just stop there. There's also plowing disturbs the soil, heavy machinery compacts the soil so it can harm fertility of the soil as well. And the machinery part of the equation has long been a source of inequality in terms of being very expensive for farmers. It's been one of the main reasons farmers have often been driven into debt. Farm machinery might have been liberating in one sense to allow increased production, but it did come with costs that we should acknowledge. We also need to recognize the ecological and social costs associated with the fertilizer industry. And this industry goes way back to the 1840s and we saw the rise of the guano trade. And we can think immediately of the working conditions of the workers who were digging the guano in the Chincha islands of Peru. And often they were coming from Asia and facing really harsh working conditions. But then when we saw the rise of synthetic nitrogen in the early 20th Century, the cost shifted in a way towards the cost of fossil fuels. The huge amount of natural gas used in the synthesis of nitrogen. And also, the climate consequences of the nitrous oxides that come from the application of synthetic nitrogen into the soil. So again, there's like enormous ecological and social impacts from that particular input. Similarly, when we talk about seeds, the hybridization of seeds in the 1920s and 1930s also raise huge concerns about plant genetic diversity. And we know that in the last century or so we've lost around 75% of plant genetic diversity for crop genetic diversity. And this is because of the way in which we started to see the uniformity of the genetic makeup of seeds. The monocultural planting of seeds really reduced that kind of diversity. And then intellectual property protection on seeds that came with the hybridization of seeds also led to a decreased ability of farmers to save their own seed and exchange their own seed with their neighbors. So again, social ecological costs. And finally, when we talk about pesticides, we have seen enormous issues with respect to pollution runoff. This kind of bioaccumulation of these toxic chemicals that have enormous health consequences. So, all of these inputs have very large impacts in terms of their social and ecological costs. And we can even extend that to the issue of data today. There's a lot of concern about data platforms for digital farming where farmers are signing away the rights to the data that are coming from their own farms. And they don't have the kind of interoperability with other data sharing systems. And there's also a lack of clarity about who owns that data. So again, there's big issues with respect to these inputs and how they are affecting both social and ecological dynamics within the food system.  Erika - Thank you for helping us understand the social and ecological impacts of these inputs into the farming industry. Norbert - This is a really rich conversation and I want to understand a little bit more. There's a big part of your text that's about the concentration in the input sector. What does it look like today and was it always this way? That's a great question because it's almost a trick question because we tend to assume that this high level of concentration that we see today is something that's new. But what I found in my research is that the high degree of concentration actually has a long history that goes back about a century or more in some cases. And when we're looking at each of these sectors, the farm machinery, for example, is controlled. Most of the market is controlled by about just four firms. And they control around 50% of the global market. But when you look specifically at national markets in the US, for example, John Deere, you know, the largest company that makes farm machinery, it controls over 50% of the tractor market. So that's just one firm alone. It's similar dynamics when we look at fertilizer, seeds and pesticides and fertilizer, for example. Just two firms control a hundred percent of North American potash production. The four key companies control a large amount of the global fertilizer trade. In seeds, it's also very similar and in pesticides. In the seeds and pesticides that's especially interesting because since the 1980s and 1990s, the seed and pesticide companies actually merged with each other. We can't even say there's a set of seed companies and a set of chemical companies. It's actually seed and chemical companies. That's one set. And they control around 60% of the global seed market and around 70% of the global pesticide market. And that's really what prompted me to want to work on this book is that after 2015, there was a set of mergers in the seed and chemical sector that concentrated those firms even further. They used to be dominated by six firms. We used to call them the Big Six, and then they had major mergers where Bayer bought Monsanto, Dow and DuPont merged and formed Corteva. Syngenta group was bought by Chem China, and then bought by Sino Chem, a big Chinese chemical company. And then BASF bought up all the bits that the other companies were forced to sell to pass regulatory hurdles. And so, we ended up with a Big Four. And these companies produce both seeds and chemicals and have a quite an enormous impact in terms of their market dominance. Norbert - Wow. This is really important and I think it's a topic that many of us who look at the food industry aren't paying attention to. And I'm really appreciative of you laying out this concentration that's taking place. Jennifer, when reading the book, I was really struck by the fact that this is not just a book about the farmers themselves and the farming industry and the companies that provide the inputs. But you also touch upon the role of universities and university science and scientists; and also the role of government in helping to fuel or seed innovation in this sector. And, you know, here I was hoping you could talk about this important role for universities and also the government given that we're in a current moment where we're seeing a retrenchment from investments by government, and also the ability of universities to continue to seed innovation. So I was hoping you could share some of your insights.  Yes, it's certainly an interesting time on the landscape of spending on innovation and with a retrenchment of state pulling back away from supporting technological innovation and other innovations. And that's certainly true in the farm sector, and that's very different from the situation if we go back to the 1800s and see, as you mentioned, the role that the state played in terms of really trying to support innovation in these sectors. And what I argue in the book is that these firms, they got big in the first place, and they were able to consolidate in the first place, through a series of what I call market technology and policy factors. And it's kind of messy. I put them in these three big categories. But in terms of these market factors, that's what most people tend to think about when they think, 'oh, a firm got big. Maybe it's just more efficient. It's able to produce products more cheaply and therefore it just grew to be big.' And that's much more complicated than that of course. And that's because, as you said this role of technological change in which universities have played a really important role. And government support and throughout history in the US, a lot of the book focuses on the US because we have good information and data there. And the US set up the land grant college system really to support development in the agricultural sector. And that gave us, you know, a lot of the innovations that led to, for example, the hybridization of seeds. And the corporations that took up that innovation that the state supported through university research, those firms also work directly with universities in many instances, to have these kinds of collaborative relationships, to develop, herbicides, to develop seeds, to develop further farm machinery, etc. So that role of technological innovation is really important, and that innovation doesn't just come from nowhere. It doesn't just pop up. It doesn't just show up one day. Right? It comes from investment. Investment in universities and research and development. And so that has been a really important strand to develop this kind of industrial agriculture. And now we know from university research, etc., that there are some problems associated with it. Yet it's proving hard to get that kind of funding to spur a new transformation towards a more sustainable agriculture because we're not giving that kind of state support, and support to universities to do that research and innovative work to lead us towards more sustainable agriculture. So, I think there's a lot there that we need to work on. And that's some of the recommendations that I make at the end of the book. Is that we need to shore up that kind of public investment in innovation, in alternative systems to address some of the problems. So just let me tag on another question from that. Just what are the consequences then for having just a small number of firms dominating this sector and no longer having these investments in innovation? Yeah, so what we're seeing increasingly as the state has pulled away from supporting agricultural research, is that most of that agricultural research now is being done by private corporations. And the big concern there is that as you have a smaller and smaller number of very large firms dominating in the sector, their incentive to innovate actually weakens. It weakens because if there's not a lot of players in the marketplace that are doing innovative work, there's just not a lot of competition. And so why would you innovate if you don't have to? If you're already a monopoly and you're able to sell your product, there's not a lot of incentive to innovate in a way that might then decrease the sales of your old products. And so, what we're seeing is a shift in innovation from the private sector, away from these kinds of transformative innovations and much more towards what we call defensive innovations. They're innovating in ways that actually enable them to sell existing products. And many would say that the rise of agricultural biotechnology was actually that kind of a defensive innovation. It was modifying seeds to make them resistant to the application of existing herbicides. And so there was innovation, but it was actually spurring further sales in an existing product. And part of the reason for that was that it became very expensive for these companies. The regulatory hurdles became quite expensive for them to develop new herbicides. And so, they were like, 'oh, it's cheaper and faster to work with seeds. Why don't we do it this way and then we'll continue to sell the herbicides.' Which by the way, got them a lot more profit than selling the seeds. So that's why they bought up a lot of the seed companies and really consolidated in that period. And there's a longstanding concern among competition regulators, the regulators that try to prevent a huge concentration in the economy, about this question of innovation. And it's very relevant in the agricultural sector. There's this sense that if you allow too much concentration to happen, it can dampen that innovation and that takes away that dynamic, innovative spirit within the sector. It's definitely a big concern. Norbert - Jennifer, I really appreciate this. Earlier in my career I was a part of some research related to biotechnology and innovation that happens there. And one of the things that I learned about is this idea of building thickets. These sort of patent thickets where you create a series of patents that actually make it difficult for others to be able to innovate in that same way. There are these real challenges of this kind of defensive innovation. And that's just one of the challenges that you bring up in the book. And I am interested in understanding, as sort a last question, what are some of the recommendations? You mentioned public sector funding of agricultural research and many of my colleagues in my discipline have said we need more research for agriculture. Are there other areas of recommendation to address some of the concerns you raised in the book? Thanks, Norbert. Yes, definitely. And I definitely do call for greater public support for agricultural research. And that's something within the agricultural sector. And I think there we really need to focus efforts on alternative agricultural production methods. For example, agroecology, which tries to reduce the amount of external inputs, not to increase them, by using nature's own processes to achieve the same functions of diversity and pest control, etc. And what's troubling is that when the firms don't have that incentive to innovate, you know, they're definitely not going to innovate in ways that would reduce their profits. They're not going to do that. The public sector has to step in if we want to see that kind of research done. But we also need measures outside of that food and agriculture system that will benefit food and agriculture. One area is stronger antitrust policies. Policies that would prevent further mergers and acquisitions that would allow those firms to continue to get bigger and bigger. Those antitrust policies are used largely, we've got merger guidelines, for example, in North America. And in Europe, when two firms want to merge, they have to get regulatory approval to do so. And those merger guidelines really walk the regulators through what would be a merger that might dampen competition, that might weaken innovation, you know, that kind of thing. It's important that we make those rules stronger. They had become progressively weaker after the 1980s. There was this move in the regulatory space that was this kind of idea that maybe it's okay if firms get really, really big because they can benefit from economies of scale. Maybe they can bring down consumer prices and maybe we shouldn't worry so much about these other areas of control. And there's been a bit of a shift in view around this in recent years where we've seen the rise of concern about these very big companies, especially with what we see with the big tech companies taking control over all these aspects of our lives. And people are saying, wait a minute, maybe we don't want to have this just a few companies controlling so much of our lives. And so, you know, we need to think about other ways to enforce antitrust policies to make them stronger so that we foster more competition and not just focus on whether something's more expensive or not. And that's, I mean, it's a bit of a hard thing to explain to some people. Obviously, people want to see lower prices. But the idea that we have to get across is that when competition dies, when it's not there, that's when the monopoly can really raise prices. And so, we need to have that competitive marketplace in order to spur innovation and also to bring prices down. That's really important and that's a kind of agenda item that's involves food and agriculture, but it's outside of the food and agriculture sector. It encompasses more. And another area where I think we can do more is to reign in the kind of undue corporate influence on the policy process. And that's arising out of a concern that as we're seeing fewer and fewer dominant companies in the food sector, and in other sectors as well, they tend to gain more political power to influence the policy and governance process. And so, what we're seeing is heightened lobby activity. Sponsoring of scientific studies and yes, coming back to the question about universities. But as corporations get bigger, they can shape science in ways that can help them win regulatory approval for their products. We need broader policies on conflict of interest to prevent large companies from taking over the policy process. And I know that's a really salient topic in the US right now, given what's going on in the broader politics. And I think it is a broader politics issue that needs to be seriously addressed if we want to support a more transformative form of food and agriculture. These kinds of policies like stronger antitrust, better conflict of interest policies, and also support for public agricultural research are all really important steps. I don't think any one of them on their own is going to do the trick in terms of spurring this desperately needed transformation in our food systems. But together, I think, they can bring us closer to that goal. Bio Jennifer Clapp is a Tier I Canada Research Chair in Global Food Security and Sustainability and Professor in the School of Environment, Resources and Sustainability at the University of Waterloo, Canada. Dr. Clapp is currently a member of the International Panel of Experts on Sustainable Food Systems (IPES-Food) and a member of the Scientific Advisory Committee of the UN Food Systems Coordination Hub. From 2019-2023, she was a member of the Steering Committee of the High Level Panel of Experts on Food Security and Nutrition (HLPE-FSN) of the UN Committee on World Food Security, and served as Vice-Chair of that body from 2021-2023. Dr. Clapp has published widely on the global governance of problems that arise at the intersection of the global economy, food security and food systems, and the natural environment. Her most recent research projects have examined the political economy of financial actors in the global food system, the politics of trade and food security, and corporate concentration in the global food system. She has also written on policy and governance responses to the global food crisis, the political economy of food assistance, and global environmental policy and governance. Her most recent books include Food, 3rd Edition (Polity, 2020), Speculative Harvests: Financialization, Food, and Agriculture (with S. Ryan Isakson, Fernwood Press, 2018), Hunger in the Balance: The New Politics of International Food Aid (Cornell University Press, 2012), Paths to a Green World: The Political Economy of the Global Environment, 2nd Edition (with Peter Dauvergne, MIT Press, 2011), and Corporate Power in Global Agrifood Governance (co-edited with Doris Fuchs, MIT Press, 2009). Her forthcoming book, published with MIT Press (2025), is titled Titans of Industrial Agriculture: How a Few Giant Corporations Came to Dominate the Farm Sector and Why It Matters.

Chris Whitman, Minor League Medical Coordinator for the St. Louis Cardinals, joins the Inside Athletic Training podcast to talk about the PBATS One-Day Charity, which is currently raising money for the V Foundation for Cancer Research.About the One-Day CharityThe PBATS One-Day Charity is an annual charitable fundraiser established by the Minor League Coordinators under the umbrella of PBATS during the 2012 Winter Meetings. The charity was created with the mission of being able to give back to organizations with a greater cause and making an impact outside the game of baseball. This charitable fundraiser was initially based on the idea of all Minor League Athletic Trainers giving one day's meal money during Spring Training, to help support that year's charitable organization. Over the years donations have expanded across all members of baseball, both at the minor and major league levels, allowing for continued growth and success of the One-Day Charity.  Now going into our thirteenth year of the One-Day Charity Fundraiser, it was decided through a voting process that we will be honoring the V Foundation as the recipient in 2025.About the V Foundation for Cancer ResearchThe V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State University basketball coach and ESPN commentator. The Foundation has funded over $353 million in cancer research grants nationwide. The V Foundation awards 100 percent of direct donations to cancer research and related programs. The V Foundation's endowment covers administrative expenses. The Foundation awards peer-reviewed grants through a competitive award process strictly supervised by a Scientific Advisory Committee. For more information on the V Foundation, please visit v.org. To DonateTo learn more and/or donate, please visit the V Foundation One-Day Charity landing page: https://vfoundation.donordrive.com/campaign/PBATS-One-Day-CharityFor more information about PBATS and athletic training, visit pbats.com.

Michael Salter is an Associate Professor in Criminology at Western Sydney University, Australia and specializes in the study of organized sexual abuse.In addition to his work on complex trauma, Michael has researched and published widely on violence against women and children.Michael sits on the Scientific Advisory Committee and the Board of Directors of theInternational Society for the Study of Trauma and Dissociationand is an associate editor of Child Abuse Review, the peer-reviewed journal of the British Association for the Study and Prevention of Child Abuse and Neglect.In This Episodewww.OrganizedAbuse.comOrganised Sexual Abuse, by Michael SalterThe Alchemy of Wolves and Sheep: A Relational Approach to Internalized Perpetration in Complex Trauma Survivors, by Harvey L. Schwartz The Politics and Experience of Ritual Abuse: Beyond Disbelief, by Sara Scott---If you'd like to support The Trauma Therapist Podcast and the work I do you can do that here with a monthly donation of $5, $7, or $10: Donate to The Trauma Therapist Podcast.Click here to join my email list and receive podcast updates and other news.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.

This week economist Gene Tunny and activist-scholar Anitra Nelson join host Lloyd Vogelman on the couch for an unfiltered conversation that digs into the personal side of the Principle of Charity. Can two diametrically opposed thinkers meet in the middle when it's planetary survival that's at stake? BIOSGene Tunny is the Founder and Director of Adept Economics and the current President of the Queensland branch of the Economic Society of Australia. He is also an Adjunct Lecturer in economics at Griffith University and an Adjunct Fellow at the Centre for Independent Studies (CIS). He hosts the Economics Explored podcast. Gene is a former Treasury official who led teams in the Treasury's budget and industry policy divisions. Associate Professor Anitra Nelson is an activist-scholar with the Informal Urbanism Research Hub (InfUr-) at University of Melbourne. Her books include Beyond Money: A Postcapitalist Strategy (2022) and Small is Necessary: Shared Living on a Shared Planet (2018). She is co-author of Exploring Degrowth (2020) and co-editor of Post-Carbon Inclusion (2024), Housing for Degrowth: Principles, Models, Challenges and Opportunities (2018) and Food for Degrowth: Perspectives and Practices (2021). Anitra is on the Scientific Advisory Committee for the joint International Society for Ecological Economics–Degrowth Conference, to be held 24-27 June 2025, in Oslo (Norway) and holds a PhD from LaTrobe University (Australia). See more – https://anitranelson.info/CREDITSYour hosts are Lloyd Vogelman and Emile Sherman This podcast is proud to partner with The Ethics CentreFind Lloyd @LloydVogelman on Linked inFind Emile @EmileSherman on Linked In and XThis podcast is produced by Jonah Primo and Sabrina OrganoFind Jonah at jonahprimo.com or @JonahPrimo on Instagram Hosted on Acast. See acast.com/privacy for more information Hosted on Acast. See acast.com/privacy for more information.

In this episode we're joined by economist Gene Tunny and activist-scholar Anitra Nelson to ask whether degrowth can save the planet, or if we should stay the current economic course. As recently as 150 years ago, pretty much everyone was living in what we'd now call extreme poverty. Thanks to capitalism, that rate is now just 9%, with a reduction of 38% in the last 30 years alone. So what's the problem? Well, for one thing, we've been plundering the natural world to fuel our growth, with little regard for its limitations. And it's come back to bite us. A regular economist might say – no problem. Let's just price in the cost of climate pollution, and natural capital, recognising that we'll need governments to take the lead. But there's a growing challenge to market-centrism from a number of movements who share a belief that a bit more government regulation is not going to get to the root of the problem; our erroneous assumption that the natural world is limitless.Degrowth argues that we can't save the planet, or end the systemic ills of capitalism like inequality, using the tools that created the problem in the first place. That our addiction to growth needs to be cut at its roots. It argues for a paradigm shift which sees wellbeing decoupled from economic growth. It envisages a different way of being, of caring and relating to each other, of flourishing itself, that's in harmony with our more noble instincts, unperverted by our current system of exploitation. BIOSGene Tunny is the Founder and Director of Adept Economics and the current President of the Queensland branch of the Economic Society of Australia. He is also an Adjunct Lecturer in economics at Griffith University and an Adjunct Fellow at the Centre for Independent Studies (CIS). He hosts the Economics Explored podcast. Gene is a former Treasury official who led teams in the Treasury's budget and industry policy divisions. Associate Professor Anitra Nelson is an activist-scholar with the Informal Urbanism Research Hub (InfUr-) at University of Melbourne. Her books include Beyond Money: A Postcapitalist Strategy (2022) and Small is Necessary: Shared Living on a Shared Planet (2018). She is co-author of Exploring Degrowth (2020) and co-editor of Post-Carbon Inclusion (2024), Housing for Degrowth: Principles, Models, Challenges and Opportunities (2018) and Food for Degrowth: Perspectives and Practices (2021). Anitra is on the Scientific Advisory Committee for the joint International Society for Ecological Economics–Degrowth Conference, to be held 24-27 June 2025, in Oslo (Norway) and holds a PhD from LaTrobe University (Australia). See more – https://anitranelson.info/CREDITSYour hosts are Lloyd Vogelman and Emile Sherman This podcast is proud to partner with The Ethics CentreFind Lloyd @LloydVogelman on Linked inFind Emile @EmileSherman on Linked In and XThis podcast is produced by Jonah Primo and Sabrina OrganoFind Jonah at jonahprimo.com or @JonahPrimo on Instagram Hosted on Acast. See acast.com/privacy for more information Hosted on Acast. See acast.com/privacy for more information.

Under-nutrition harms health, but so does over-nutrition. The Bill and Melinda Gate's foundation has just released their Goalkeepers' report - highlighting the detrimental impact that poor nutrition is having on children's health.  Rasa Izadnegahdar, director of Maternal, Newborn, Child Nutrition & Health at the foundation joins us to explain how they are targeting nutritional interventions. Also this week, a new investigation in The BMJ has found that the UK government's  Scientific Advisory Committee on Nutrition - the people who help guide the UK's nutrition policy - have competing interests with the food industry. We hear from Chris van Tulleken, University College London; Rob Percival, the Soil Association; and Alison Tedstone, chair of the Association for Nutrition.   Reading list: Goalkeepers Report 2024 UK government's nutrition advisers are paid by world's largest food companies, BMJ analysis reveals    

Description: Co-hosts Ryan Piansky, a graduate student and patient advocate living with eosinophilic esophagitis (EoE) and eosinophilic asthma, and co-host Holly Knotowicz, a speech-language pathologist living with EoE who serves on APFED's Health Sciences Advisory Council, have a conversation about the latest findings from the EGID Partners Registry.   In this episode, Ryan and Holly discuss with Dr. Elizabeth Jensen two studies drawn from data obtained by EGID Partners Registry questionnaires. One study focuses on extraintestinal pain experienced by patients living with EoE and other eosinophilic gastrointestinal disorders (EGIDs). The second study considers vitamin and iron deficiencies reported by patients living with EoE and other EGIDs. Dr. Jensen hints at connected research she would like to pursue next. Listen for more information about extraintestinal pain, vitamin deficiencies, EoE, and EGIDs.   Disclaimer: The information provided in this podcast is designed to support, not replace the relationship that exists between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:58] Ryan Piansky introduces the episode. He and co-host Holly Knotowicz will talk about the latest findings from the EGID Partners Registry.   [1:28] Holly introduces Dr. Elizabeth Jensen, an Associate Professor at the Wake Forest School of Medicine and an Adjunct Professor in the Department of Medicine at the University of North Carolina at Chapel Hill.   [1:58] Dr. Jensen has been working on research related to eosinophilic gastrointestinal diseases since she was in graduate school.   [2:11] Dr. Jensen's background is in maternal and child health. She was interested in how early life exposures alter colonization of the gut microbiome and how that can lead to immune dysregulation.   [2:33] Dr. Jensen became interested in EoE and eosinophilic gastrointestinal diseases because her family members had been affected by these conditions and researchers knew next to nothing about the pathogenesis of these conditions.   [2:52] Dr. Jensen's early research explored early life exposures that relate to the development of eosinophilic gastrointestinal diseases.   [3:02] That research paved the way for a variety of ongoing research studies in Denmark, the U.S., and through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).   [3:30] The Eosinophilic Gastrointestinal Disorders (EGID) Partners Registry is a registry of individuals who have been diagnosed with any one of the eosinophilic gastrointestinal diseases or multiple ones.   [4:21] The registry is also for individuals who haven't been diagnosed. The EGID Partners Registry gives a voice to individuals who are living with these conditions, in terms of directing where we go with research and asking patient-centered questions.   [4:58] To participate in the registry, go to EGIDPartners.org and register. Once you have registered you will receive a link to a questionnaire. The questionnaire can seem long.   [5:23] After the first questionnaire, the registry sometimes asks for updates to your baseline information and asks new questions that have been suggested by others.   [5:45] The EGID Partners Registry has a Scientific Advisory Committee, and patient advocacy groups, including APFED, physicians, and researchers, who direct where to go with the rich data that has been collected.   [6:07] Some of the questions are specific and asked by registry members with individual interests. Some of the questions are directed by input received by patient advocacy groups.   [6:48] After collecting these data, EGID Partners analyzes them and disseminates them by presenting them at meetings to get information to providers and individuals affected by these conditions.   [7:50] EGID Partners Registry did a study titled “Extraintestinal Symptoms of Pain in Eosinophilic Gastrointestinal Diseases” and published a poster on it. They explored joint pain, leg pain, and headaches, to see if they were related to an eosinophilic condition.   [8:29] They studied pain severity and frequency as well as migraines. A high proportion of individuals reported pain. They studied those with EoE only and those with another EGID, including eosinophilic gastritis, eosinophilic enteritis, and eosinophilic colitis.   [9:06] The second group included individuals with or without EoE. In general, patients who have one of these non-EoE EGIDS, with or without EoE, tend to experience more frequent pain and more severe pain.   [9:30] They've also seen that result in looking at other comorbidities. It reinforces the idea that patients who have multi-segmental EGIDs, or one of these lower EGIDS, tend to experience, on average, more severe extraintestinal symptoms.   [10:39] The three areas of pain highlighted on the poster were legs, joints, and headaches. This was based on feedback from patients saying, “This is what we're experiencing, is it something that you could look into?”   [10:48] It doesn't preclude the possibility that there may be other types of extraintestinal manifestations that we should be looking at in the future.   [11:27] This study by the EGID Partners Registry feels very impactful to Dr. Jensen. It brings awareness to some of the challenges that individuals with these conditions are experiencing. Holly points out it's a way for patients to get access to experts.   [12:20] In this study, the EGID Partners Registry also looked at what proportion of individuals were taking either over-the-counter pain management medications or prescription medication. [12:39] About the migraine headache pain, most of it was over-the-counter use, although some reported prescription medication.   [12:54] Ryan grew up experiencing leg pain all the time. He attributed it to his other chronic disorders. It wasn't until some years ago at an APFED conference that he heard a physician mention leg pain. Ryan had never considered it as an EoE symptom. [13:38] One of the challenges the EGID Partners Registry has is that they don't have enough individuals registered to start dividing the sample up further, by age. Roughly two-thirds of the respondents were adults. [14:12] It's also hard to get kids to report accurately what they are experiencing. It often comes down to the caregiver reporting it to the EGID Partners Registry, which brings its challenges.   [14:34] Ryan calls all patients listening to sign up with the EGID Partners Registry to allow the registry to get to some of these deeper questions.   [14:47] Dr. Jensen adds that people often want to understand why these pains are connected to EGIDs. EGID Partners Registry doesn't know why.   [15:02] There are underlying biological processes that could potentially contribute to this observation of the increased prevalence of extraintestinal pain manifestations. In the EGID population, there is the enrichment of connective tissue disorders and more.   [15:36] There is also evidence that there are increased comorbidities associated with a more inflammatory milieu. That could contribute to these extraintestinal manifestations of pain.   [15:55] Dr. Jensen hopes to bring greater awareness to patients and providers, honoring what the patient is experiencing and digging a little deeper to understand what may be going on for this patient.   [16:17] EGID Partners Registry also did a study on vitamin deficiency and supplement use among patients with EGIDs. They looked at those who had been diagnosed with EoE alone and those who had another EGID, with or without EoE.   [16:47] In this study, unlike with the pain manifestation, they didn't see a statistically significant difference between EoE alone and the other EGIDs. There was some higher proportion in those with the lower EGIDs, but it didn't reach statistical significance.   [17:16] They saw a high proportion reporting physician-diagnosed vitamin deficiency, mainly Vitamin D and a few others. That suggests the need to screen patients for vitamin deficiency with a new diagnosis and when monitoring response to therapy.   [18:28] There are reasons why there could be vitamin deficiencies. You may have a restrictive diet or be avoiding certain foods because you know they are going to bother you, or for the lower EGIDs, it may be that you're experiencing malabsorption.   [19:04] Holly plans to send this study to the people she is working with. She will ask them to read it, and then work to get a baseline.   [19:56] A patient could ask for this test from any provider. Dr. Jensen says if it helps them to bring the evidence from these papers, that's great; she hopes this empowers patients when they talk with their providers about the care that makes sense for them.   [20:41] EGID Partners Registry compared those reporting a deficiency between those with EoE alone and those without EoE. Eighty-two percent of those with EoE reported a Vitamin D deficiency. About a fourth of each group reported a B12 deficiency.   [21:27] Iron was another deficiency reported by 55% in the EoE group and 69% in the Non-EoE EGID group. Vitamins D and B12, and Iron were the top deficiencies reported. Many of the respondents reported they were taking vitamins or dietary supplements.    [22:32] Dr. Jensen thinks a nice follow-up study to this would be to learn the proportion of respondents taking vitamin injections or infusions because of malabsorption issues with oral supplements.   [22:37] Dr. Jensen thinks this study likely reflects an under-ascertainment of vitamin deficiency. A lot of patients aren't getting screened. We don't have the data yet because it's not a universal recommendation to screen for vitamin deficiencies.   [23:01] Dr. Jensen thinks awareness and increased screening will be key. Then we can start thinking about how we mitigate this.   [23:24] Patients did not report symptoms of vitamin deficiencies. Dr. Jensen thinks that's another good follow-up question. She stresses that it's important to screen for deficiencies whether or not symptoms of deficiencies are present.   [24:06] Holly considers her patients with various symptoms of vitamin deficiencies and wants to get on the website and ask questions. Dr. Jensen tells her there is a link on the registry site where you can suggest a question. She asks Holly to suggest a question!   [24:30] Patients were asked if they have ever had a vitamin deficiency and were also asked if they currently take vitamins or supplements. A vitamin pill is one type of supplement.   [25:10] The study also looked at the use of a variety of complementary and alternative medicine approaches that patients turn to because they're not getting adequate relief from traditional approaches to addressing their conditions.   [25:34] They saw a higher proportion of individuals with non-EoE EGIDs reporting the use of these kinds of alternative treatment approaches. Roughly a fourth of non-EoE EGID patients reported the use of a chiropractor, vs. 10% of EoE patients.   [26:11] Roughly one-fourth of non-EoE EGID patients reported turning to different herbal approaches in trying to get some relief for their conditions.   [26:49] Dr. Jensen says as a researcher, whenever she does a study, she is led to more questions. All of the research so far has opened the door to many more questions, including questions about individuals who don't have either EoE or another EGID.   [27:20] Dr, Jensen wonders, is this extraintestinal pain unique to those who have EoE and non-EoE EGIDs? How do we best mitigate this? What does the workup look like for the patient coming in with joint pain or leg pain?   [27:37] How can we understand the factors that contribute to this pain? How do we get providers thinking about screening for vitamin deficiencies so we have a better understanding of their prevalence in this patient population?   [28:04] If patients are not absorbing vitamins orally, How do we mitigate this? How do we optimize their nutrition so they are not dealing with vitamin deficiencies which can lead to other consequences down the road?   [28:24] The surprises are always, “What doors are getting opened as a result?” We've answered some questions but there are so many questions that we still need to answer.   [28:56] Ryan asks if a correlation was found in these studies between vitamin deficiencies and extraintestinal pain. He notices that missing his vitamins correlates with more leg pain. Dr. Jensen asks Ryan to go onto the website and pose that question!   [29:10] Dr. Jensen has not looked at the data in that way but she thinks it would be an interesting way to bring these two studies together and try to explain some of what they are observing.   [29:21] Holly thanks Dr. Jensen for sharing her expertise and this fascinating research to help all EGID patients have less painful and better quality lives.   [29:52] Dr. Jensen makes this request. “Please consider checking out the EGID Partners Registry website, joining, learning more about how you can contribute to this research, and introducing questions.”   [30:04] “We're always looking for new questions and are excited to think about how we can partner with patients in addressing questions that matter to them. Help us continue to answer some of these critical questions.”   [30:32] One topic Dr Jensen is interested in researching is the implications for reproductive health for having these conditions. Some research in another data source suggests potential implications.   [30:54] EGID Partners Registry observed and reported this year that there may be some indication of a longer time to pregnancy and a lower proportion of EGID patients experiencing a pregnancy. They want to look at that and understand it better.   [31:12] They want to understand it with more detail than they can get from the administrative data source with the initial questionnaire. EGID Partners Registry is pushing out a reproductive health history questionnaire now.   [31:29] EGID Partners Registry needs individuals to join and respond to the reproductive health questionnaire to help them understand this more deeply and some of the findings they are seeing initially in some of these other data sources.   [31:49] Ryan encourages listeners to learn more about Dr. Jensen's research and EGID Partners Registry by visiting EGIDPartners.org. To learn more about eosinophilic gastrointestinal disorders, visit APFED.org/egids.   [32:13] To find a specialist in eosinophilic disorders, use APFED's Specialist Finder at APFED.org/specialist. To connect with others impacted by eosinophilic diseases, join APFED's online community on the Inspired network at APFED.org/connections.   [32:31] Ryan thanks Dr. Jensen for joining us on Real Talk. Dr. Jensen thanks Ryan and Holly for having her on the podcast to talk about this research. Holly also thanks Education Partners, GSK, Sanofi, and Regeneron for supporting this episode.   Mentioned in This Episode: Dr. Elizabeth Jensen PhDAssociate Professor at Wake Forest University School of MedicineAdjunct Professor in the Department of Medicine at the UNC at Chapel Hill Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) EGID Partners Registry Digestive Disease Week (DDW)   “Extraintestinal Symptoms of Pain in Eosinophilic Gastrointestinal Diseases” “Frequent Report Of Vitamin Deficiencies And Use Of Supplements And Complementary/Alternative Treatment Approaches In Patients With Eosinophilic Gastrointestinal Diseases” (EGIDPartners Registry) APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Real Talk: Eosinophilic Diseases Podcast apfed.org/egids apfed.org/specialist apfed.org/connections   Education Partners: This episode of APFED's podcast is brought to you thanks to the support of GSK, Sanofi, and Regeneron.   Tweetables:   “The Eosinophilic Gastrointestinal Disorders (EGID) Partners Registry is a registry of individuals who have been diagnosed with any one of the eosinophilic gastrointestinal diseases or with multiple ones.” — Dr. Elizabeth Jensen   “The EGID Partners Registry studied extraintestinal pain severity and frequency and migraines. There was a high proportion of individuals reporting experiencing pain.” — Dr. Elizabeth Jensen   “EGID Partners Registry also did a study on vitamin deficiency and supplement use among patients with EGIDs.” — Dr. Elizabeth Jensen   “Is this unique to EoE and non-EoE EGIDs? … How do we best mitigate this for the patient who is coming in with joint pain or leg pain? What does the workup look like for those patients?” — Dr. Elizabeth Jensen   “The surprises are always, ‘What doors are getting opened as a result?' We've answered some questions but there are so many questions that we still need to answer.” — Dr. Elizabeth Jensen

Content advisory: this episode makes mention of the sexual assault and murder of a child. Please take care if listening. In this special update episode of Admissible, Tessa Kramer returns to the mic to explore the aftermath of our 12-part series. Our investigation exposed the Virginia state crime lab's mishandling of a whistleblower's allegations against Mary Jane Burton, the lab's long-time Chief Serologist. Since our initial reporting, the Virginia Department of Forensic Science and its Scientific Advisory Committee have taken steps to confront the fallout. This episode highlights the case of Marvin Grimm, who spent 45 years in prison. The egregious nature of Burton's flawed evidence in this case not only clears Grimm's name, but also underscores the urgent need for the lab to take more drastic action in responding to our concerns about Mary Jane Burton. Audio of Mary Jane Burton testimony is from the Jens Soering trial. For more about that trial, we recommend the 2023 documentary "Till Murder Do Us Part: Soering vs. Haysom or the podcast, Small Town Big Crime Podcast - https://www.smalltownbigcrimepodcast.com/ --- Produced and edited by: Tessa Kramer and Ellen Horne Mixed and scored by: Charles Michelet Special thanks to: Megan Pauly, Ben Paviour, Meg Lindholm, Gavin Wright, Chloe Wynne, Dana Bialek, Danielle Elliot, Kim Nederveen Pieterse, and Steve Humble. --- Listen now on (https://admissible.vpm.org) or your favorite podcast platform. Learn more about your ad choices. Visit megaphone.fm/adchoices

Synopsis: In this episode of Biotech 2050, host Alok Tayi, CEO and co-founder of Vibe Bio, speaks with Dr. Bruce Leuchter, President and CEO of Neurvati Neuroscience. They discuss capital markets, neurology, psychiatry, and Neurvati's work in ultra-rare diseases. Dr. Leuchter shares his journey from clinical training to leadership at Neurvati. The conversation covers the convergence of neurology and psychiatry, advanced technologies in drug development, and addressing unmet medical needs in neuroscience. Join us for insights into the future of biotech and developments in neuroscience. Biography: Dr. Bruce Leuchter brings deep-rooted, wide-ranging experience to his role as President and CEO at Neurvati, spanning neuroscience, clinical neuropsychiatry, biotechnology equity research, healthcare investment banking and entrepreneurship. His expertise captures all aspects of building and leading a neuroscience company, and his experiences have generated deep empathy for the patient journey. Across his many roles in the clinic, industry, and beyond, Dr. Leuchter has maintained a passion for knowledge and has aimed to purposefully apply that knowledge to help patients suffering from diseases of the brain and nervous system. A physician by training and neuropsychiatrist by specialty, Dr. Leuchter completed residency training in Neurology and Psychiatry at New York Presbyterian Hospital and Weill Cornell Medical College and is a Diplomate of the American Board of Psychiatry and Neurology. Dr. Leuchter served as Director of Clinical Neuropsychiatry at Weill Cornell Medical College and maintains a voluntary faculty appointment in the Department of Psychiatry. Dr. Leuchter has also held multiple financial services roles including biotechnology equity research at Goldman Sachs, healthcare investment banking at Credits Suisse, and biotechnology mergers and acquisitions at PJT Partners, all of which drive a nuanced understanding of the biotechnology industry and particularly the neuroscience ecosystem. Dr. Leuchter is Co-Founder and Founding Neuropsychiatrist of a digital therapeutics company, Click Therapeutics, which specializes in the treatment of neurological and psychiatric disorders. He serves as a member of the Scientific Advisory Committee for the Daedelus Fund for Innovation at Weill Cornell Medical College, as a member of the Life Science Institute Leadership Council at the University of Michigan, as a member of the Advisory Board at Michigan Drug Discovery, and as a Business Advisory Board member at FOXG1 Research Foundation.

Just because you have Osteoporosis doesn't mean you can no longer lead an active lifestyle or you have to stay indoors to minimize the risk of falls and fractures.    Certain kinds of high-intensity loading can be safe and effective even for people with low bone mass if supervised under the right conditions. And that's what Dr. Belinda Beck and I are discussing today.   Dr. Belinda Beck, a powerhouse in the field of bone health, holds a BMHS(Ed), MS, PhD, and FACSM and is a professor in the School of Health Sciences & Social Work at Griffith University.    She developed Onero™, an evidence-based exercise program based on the LIFTMOR study conducted at Griffith University. With over 20 years of teaching musculoskeletal anatomy and conducting bone research, her expertise has garnered national and international recognition.    Dr. Beck serves on the Medical and Scientific Advisory Committee of Healthy Bones Australia (formerly Osteoporosis Australia) and the Healthy Bones Australia National Consumer Advisory Committee.    Discover how Onero™ can improve your quality of life in today's informative episode of the Happy Bones, Happy Life podcast! “A number on the DEXA scan doesn't even matter to me as long as the quality of life is improving. That's what I care about as a human, not as a researcher. As a postmenopausal person, I'm at risk like everybody else. So I care what my quality of life is like.” - Dr. Belinda Beck     In this episode: - [04:17] - What is Onero™? - [08:33] - Delivering Onero™ to people who need it - [14:47] - Reduction in fractures and falls with the use of Onero™ - [20:52] - Transforming couch potatoes into strong and active women - [23:28] - Who can or can't do Onero™? - [28:36] - Learn what makes the program safe and how you can become an accredited Onero™ coach - [33:14] - How to find a certified Onero™ coach in your area - [36:09] - Onero™ training program for providers   Resources mentioned - The Bone Clinic Website - https://theboneclinic.com.au/ - Become an Onero™ Academy Accredited Practitioner - https://onero.academy/ - Discounted supplements through Fullscript - https://us.fullscript.com/welcome/mbissinger - Website for Dr. Claudia Tamas' Onero™ program in NJ - https://www.nmrnj.com/   More about Margie - Website - https://margiebissinger.com/  - Facebook - https://www.facebook.com/p/Margie-Bissinger-MS-PT-CHC-100063542905332/  - Instagram - https://www.instagram.com/margiebissinger/?hl=en    DISCLAIMER – The information presented on this podcast should not be construed as medical advice. It is not intended to replace consultation with your physician or healthcare provider. The ideas shared on this podcast are the expressed opinions of the guests and do not always reflect those of Margie Bissinger and Happy Bones, Happy Life Podcast. *In compliance with the FTC guidelines, please assume the following about links on this site: Some of the links going to products are affiliate links of which I receive a small commission from sales of certain items, but the price is the same for you (sometimes, I even get to share a unique discount with you). If I post an affiliate link to a product, it is something that I personally use, support, and would recommend. I personally vet each and every product. My first priority is providing valuable information and resources to help you create positive changes in your health and bring more happiness into your life. I will only ever link to products or resources (affiliate or otherwise) that fit within this purpose.

In this episode of Robin's Nest, Georgia Boyer talks with Haley Grimes, Director of American Humane's Farm Program Operations. American Humane is a leader in improving animal welfare in agriculture and has created standards in concert with a Scientific Advisory Committee comprised of leading experts in agriculture, species-specific animal behavior, and ethics. Certified farmers create an environment that fosters the mental and physical well-being of animals by providing, among other things, appropriate space, lighting, air quality, food, and water to their animals.

On “Food Talk with Dani Nierenberg'' Dani moderates a discussion about new research and tools that can help the world adapt to a changing climate, protect agrobiodiversity, and transform our approach to and understanding of food and nutrition. Speakers dive into the architecture of a food system that will help eaters make sustainable choices, the recent work that aims to better understand diets around the globe, and measuring progress from farm to plate.  Speakers include Jessica Fanzo, Professor of Climate and Director of the Food for Humanity Initiative at the Columbia Climate School; Anna Herforth, Senior Research Associate at the Harvard T.H. Chan School of Public Health and a member of the Periodic Table of Food Initiative's Scientific Advisory Committee; Gary Paul Nabhan, a writer, ethnobiologist, Research Social Scientist Emeritus at the University of Arizona, and the Co-Founder of Native Seeds/SEARCH; Andy Jarvis, Director of Future of Food at the Bezos Earth Fund; and Jonathan Lundgren, the Founder and Director of the Ecdysis Foundation. While you're listening, subscribe, rate, and review the show; it would mean the world to us to have your feedback. You can listen to “Food Talk with Dani Nierenberg” wherever you consume your podcasts.

On this episode we'll talk about shared decision-making - when a patient and their healthcare practitioner work together to discuss and create a personalized approach to care with guests Karen Camp, a patient advocate who is living with psoriasis, and Dr. Jason Hawkes, a medical dermatologist in the greater Sacramento area who serves on the Medical Board and Scientific Advisory Committee of NPF. This podcast episode is sponsored by UCB. 

Join me on the latest episode of Ageless by Rescu as we dive into the world of personalised aesthetics treatment plans with Suzie Hoitink, a member of the Scientific Advisory Committee for the Australian Non Surgical Symposium (NSS). With over two decades of experience as an aesthetics entrepreneur and healthcare professional, Suzie is a highly sought-after advisor in the industry. Her mission? To revolutionise patient safety, results, and care through training, support, and education for doctors and nurses in their practices. In this conversation, we explore the future of aesthetic procedures, evolution of clinics and the exciting advancements in non-surgical treatments available to consumers. Discover how multimodality treatment plans are your best friend, and can help you achieve natural, safe, and long-lasting results on your aesthetic journey. Suzie's expertise extends beyond treatments alone. She shares invaluable insights on selecting the right practitioner who will genuinely understand your goals, budget, and safety concerns. With her guidance, you'll be empowered to collaborate with an aesthetics professional who will create a bespoke aesthetic plan tailored just for you. But that's not all- Suzie's passion for the healthcare industry's future shines through as she highlights the tremendous potential for innovation in both clinical and business practices. Get excited for a future where aesthetic practices become even more sophisticated and safer for every patient. I'm so delighted to give you exclusive access to Suzie Hoitink's wealth of knowledge so we can discover the possibilities that lie ahead in the world of personalised aesthetics.  Listen to the full podcast here: https://omny.fm/shows/ageless-by-rescu/suzie-hoitink-member-of-non-surgical-symposiumSee omnystudio.com/listener for privacy information.

Professor Kamper shares his expertise on how researchers can bridge the gap to assist clinicians in comprehending scientific findings effectively, while also empowering clinicians to interpret and apply the science within their practice adeptly. An engaging conversation that sheds light on the symbiotic relationship between research and clinical application, ultimately improving patient care and outcomes.   Dr Steve Kamper is Professor of Allied Health at the School of Health Sciences and Nepean Blue Mountains Local health District. He has been continuously supported by NHMRC fellowships since 2008, and is currently a NHMRC Emerging Leader Fellow . He has over 190 publications in peer-reviewed journals, has presented his work in >10 countries, and received >$5 million in competitive research funding from Australia, Ireland, Canada, and Norway. Steve is senior editor of the Journal of Orthopaedic and Sports Physial Therapy, associate editor in the Cochrane Back and Neck Group, Vice-chair of the Executive Orgainsing Committee of the International Back and Neck Pain Forum, and member of the Scientific Advisory Committee of the Australia New Zealand Musculoskeletal Clinicial Trials Network. Supporting and connecting early career researchers is an important part of Steve's professional life. In 2011 he established the International Collaboration of Early Career Researchers (http://the icecream.org), he has provided input regarding ECR programming at International conferences, conducts mentoring and training, and gives lectures on academic skills such as writing and presenting.   https://pubmed.ncbi.nlm.nih.gov/29852833/ Evidence in Practice: A New Series for Clinicians   The series "Evidence in Practice" by Professor Steven Kamper is designed to bridge the gap between research and clinical application. In this series, clinicians can expect to find valuable insights into effectively incorporating scientific evidence into their daily practice. Kamper's work aims to empower clinicians with the knowledge and tools they need to make informed decisions, ultimately enhancing patient care and outcomes. Whether you're a seasoned practitioner or a budding clinician, "Evidence in Practice" offers a practical and informative resource to help you navigate the complexities of evidence-based healthcare.

Professor Thomas Seyfried is an American professor of biology, genetics, and biochemistry at Boston College. He received his PhD from the University of Illinois Urbana-Champaign in 1976. His postdoctoral fellowship studies were in the Department of Neurology at the Yale University School of Medicine where he served as an assistant professor in neurology. Professor Seyfried's research focuses on mechanisms of chronic diseases such as cancer, epilepsy, neurodegenerative lipid storage diseases, and caloric restriction diets. Prof. Seyfried has been published in over 150 peer-reviewed publications. He previously served as chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro. His 2012 book is Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer. In this episode today, Prof. Seyfried, and I discuss: - What is cancer? - Current outlooks for cancer treatments - The causes of cancer - Metabolic therapy vs other forms of cancer treatment - Empirical data for metabolic therapy - Common rebuttals to metabolic therapy - Water only fasting vs the keto diet - Cancer prevention & more! Connect with us: https://freedompact.co.uk/newsletter​ (Healthy, Wealthy & Wise Newsletter) https://instagram.com/freedompact​ tiktok.com/personaldevelopment https://twitter.com/freedompactpod freedompact@gmail.com Connect with Prof. Seyfried: https://cancerevolution.film https://www.bc.edu/bc-web/schools/mca... DISCLAIMER: The content provided by the Freedom Pact Podcast is for educational and entertainment purposes only. Our content is not intended to constitute or be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have heard on the podcast or on our social media or other platforms.

In this week's episode of "Pushing the Limits I had the privilege of interview world renown cancer researcher Professor Thomas Seyfried the author of over 150 peer reviewed publications and the author of the book "Cancer as a Metabolic Disease"   For 30 years Professor Seyfried has been in the trenches as a geneticist and biochemist studying cancer cells and working out the intricacies of how to stop them proliferating. He says there are two primary fuels that cancer cells use in their abhorrent metabolism, Glucose and Glutamine and that if we can cut the fuel supply of these two things to the cancer cells we have a powerful non toxic way of killing cancer cells. He and colleagues designed the Press-pulse: a novel therapeutic strategy for the metabolic management of cancer and in this interview we dive into his latest research and what you can do if you have cancer or want to lower your chances of getting cancer.   If you enjoyed this episodes make sure to check out our Ebook/Interview series "What Your Oncologist isn't telling you" Ebook  with 20 world leading experts on this approach and adjunct therapies.   People can donate to Professor Seyfried's crucial work via this link the https://foundationformetaboliccancertherapies.com/   Dr Thomas Seyfried Bio Thomas N. Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He also holds a Master's degree in Genetics from Illinois State University. Thomas Seyfried served with distinction in the United States Army's First Cavalry Division during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, the Ketogenic Diet Special Interest Group of the American Epilepsy Society, the Academy of Comprehensive and Complementary Medicine, and the American College of Nutrition. Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor. Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer(Wiley, 1st ed., 2012).   Health Optimisation and Life Coaching with Lisa Tamati Lisa offers solution focused coaching sessions to help you find the right answers to your challenges. Topics Lisa can help with:  Lisa is a Genetics Practitioner, Health Optimisation Coach, High Performance and Mindset Coach. She is a qualified Ph360 Epigenetics coach and a clincian with The DNA Company and has done years of research into brain rehabilitation, neurodegenerative diseases and biohacking. She has extensive knowledge on such therapies as hyperbaric oxygen,  intravenous vitamin C, sports performance, functional genomics, Thyroid, Hormones, Cancer and much more. Testing Options Comprehensive Thyroid testing DUTCH Hormone testing Adrenal Testing Organic Acid Testing Microbiome Testing Cell Blueprint Testing Epigenetics Testing DNA testing Basic Blood Test analysis She can help you navigate the confusing world of health and medicine and can advocate for you. She can also advise on the latest research and where to get help if mainstream medicine hasn't got the answers you are searching for whether you are facing challenges from cancer to gut issues, from depression and anxiety, weight loss issues, from head injuries to burn out.: Consult with Lisa    Join our Patron program and support the show Pushing the Limits' has been free to air for over 8 years. Providing leading edge information to anyone who needs it. But we need help on our mission.  Please join our patron community and get exclusive member benefits (more to roll out later this year) and support this educational platform for the price of a coffee or two You can join by going to  Lisa's Patron Community   Lisa's Anti-Aging and Longevity Supplements  Lisa has spent years curating a very specialised range of exclusive longevity, health optimising supplements from leading scientists, researchers and companies all around the world.  This is an unprecedented collection. The stuff Lisa wanted for her mum but couldn't get in NZ. Check out the range at her LongLifeLabs shop   Subscribe to our popular Youtube channel  with over 600 videos, millions of views, a number of full length documentaries, and much more. You don't want to miss out on all the great content on our Lisa's youtube channel. Youtube   Order Lisa's Books My latest book Relentless chronicles the inspiring journey of how my mother and I defied the odds after an aneurysm left my mum, Isobel, with massive brain damage at age 74. The medical professionals told me there was absolutely no hope of any quality of life again. Still, I used every mindset tool, years of research and incredible tenacity to prove them wrong and bring my mother back to full health within three years. Get your copy here: Lisa's Books   Our NMN Bio Flagship Longevity Range A range by molecular biologist Dr Elena Seranova NMN: Nicotinamide Mononucleotide, an NAD+ precursor Researchers have found that Nicotinamide Adenine Dinucleotide or NAD+, a master regulator of metabolism and a molecule essential for the functionality of all human cells, decreases dramatically over time.   What is NMN? NMN Bio offers a cutting edge Vitamin B3 derivative named NMN (beta Nicotinamide Mononucleotide) that can boost the levels of NAD+ in muscle tissue and liver. Take charge of your energy levels, focus, metabolism and overall health so you can live a happy, fulfilling life. Founded by scientists, NMN Bio offers supplements of the highest purity and rigorously tested by an independent, third-party lab. Start your cellular rejuvenation journey today.   Support Your Healthy Aging We offer powerful third-party tested NAD+ boosting supplements so you can start your healthy ageing journey today. Shop now: NMNBIO NMN (beta Nicotinamide Mononucleotide) 250mg | 30 capsules NMN (beta Nicotinamide Mononucleotide) 500mg | 30 capsules 6 Bottles | NMN (beta Nicotinamide Mononucleotide) 250mg | 30 Capsules 6 Bottles | NMN (beta Nicotinamide Mononucleotide) 500mg | 30 Capsules Boost Your NAD+ Levels — Healthy Ageing: Redefined Cellular Health Energy & Focus Bone Density Skin Elasticity DNA Repair Cardiovascular Health Brain Health Metabolic Health Listen to the episodes with Dr Seranova on the show: https://www.lisatamati.com/podcast--dr-elena-seranova/ https://www.lisatamati.com/podcast--dr-elena-seranova-part-3/   Perfect Amino Supplement by Dr David Minkoff Introducing PerfectAmino PerfectAmino is an amino acid supplement that is 99% utilized by the body to make protein. PerfectAmino is 3-6x the protein of other sources with almost no calories. 100% vegan and non-GMO. The coated PerfectAmino tablets are a slightly different shape and have a natural, non-GMO, certified organic vegan coating on them so they will glide down your throat easily. Fully absorbed within 20-30 minutes! No other form of protein comes close to PerfectAminos Listen to the episode with Dr MInkoff here:  Ketone Products by HVMN The world's best  exogenous Ketone IQ Listen to the episode with Dr Latt Mansor Lisa's  ‘Fierce' Sports Jewellery Collection For Lisa's gorgeous and inspiring sports jewellery collection, 'Fierce', go to Jewellery   For Vielight Device Vielight brain photobiomodulation devices combine electrical engineering and neuroscience. To find out more about photobiomodulation, current studies underway and already completed and for the devices mentioned in this video go to www.vielight.com Use code "tamati" at checkout to get a 10% discount on any of their devices.   Enjoyed This Podcast? If you did, subscribe and share it with your friends! If you enjoyed tuning in, then leave us a review and share this with your family and friends. Have any questions? You can contact my team through email (support@lisatamati.com) or find me on Facebook, Twitter, Instagram and YouTube. For more episode updates, visit my website. You may also tune in on Apple Podcasts. To pushing the limits, Lisa and team

Join me on the latest episode of Ageless by Rescu as we dive into the world of personalised aesthetics treatment plans with Suzie Hoitink, a member of the Scientific Advisory Committee for the Australian Non Surgical Symposium (NSS). With over two decades of experience as an aesthetics entrepreneur and healthcare professional, Suzie is a highly sought-after advisor in the industry. Her mission? To revolutionise patient safety, results, and care through training, support, and education for doctors and nurses in their practices. In this conversation, we explore the future of aesthetic procedures, evolution of clinics and the exciting advancements in non-surgical treatments available to consumers. Discover how multimodality treatment plans are your best friend, and can help you achieve natural, safe, and long-lasting results on your aesthetic journey. Suzie's expertise extends beyond treatments alone. She shares invaluable insights on selecting the right practitioner who will genuinely understand your goals, budget, and safety concerns. With her guidance, you'll be empowered to collaborate with an aesthetics professional who will create a bespoke aesthetic plan tailored just for you. But that's not all- Suzie's passion for the healthcare industry's future shines through as she highlights the tremendous potential for innovation in both clinical and business practices. Get excited for a future where aesthetic practices become even more sophisticated and safer for every patient. I'm so delighted to give you exclusive access to Suzie Hoitink's wealth of knowledge so we can discover the possibilities that lie ahead in the world of personalised aesthetics.  Watch the episode here: https://youtu.be/u5yHwLyrRNw Book a one on one Ageless Coaching session with BaharI'm so pleased to now offer one one one mentoring, coaching sessions, VIP membership and the opportunity to ask me specific questions via the Sunroom platform. This is the first and only place I'll be offering in depth, personal and exclusive content that I don't share here or on my social platforms. I am excited to personally support your Ageless journey in a private and supportive space. Join Sunroom to learn more about my membership which is only $15 a month and VIP Custom Experiences ranging from quick questions to in-depth coaching. Join my Sunroom Here https://sunroom.so/BE.AgelessSee omnystudio.com/listener for privacy information.

Is There A Greater Risk Of Brain Cancer From Cell Phone Use For Younger People? Dr. Thomas Seyfried, • Contact: thomas.seyfried@bc.edu • Book – Cancer as a Metabolic Disease #ThomasSeyfried#Cancer #MetabolicDisease Dr. Thomas Seyfried, is a professor and author publishing a groundbreaking book; Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer.This book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism.  However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited.  This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requiring metabolic solutions for its management and prevention.  Support for this position is derived from critical assessment of current cancer theories.  Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate. The book also provides extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet. Experts in the cancer research field have praised this comprehensive study as one of science's hottest topics. Dr. Thomas Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He has a Master's degree in Genetics from Illinois State University.  Thomas Seyfried served with distinction in the United States Army's during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society.  Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor.  Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).” To Contact Dr Thomas N. Seyfried, Ph.D. email:  thomas.seyfried@bc.edu Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Wondering when to consider JAK inhibitors? We've got just the expert. This week, we're joined by Dr. Jason Hawkes as he outlines just when clinicians should consider implementing JAK inhibitors. Listen in as he talks about the many factors of JAK inhibitor treatments and practical tips for counseling patients on systemic therapies. Each Thursday, join Dr. Raja and Dr. Hadar, board certified dermatologists, as they share the latest evidence based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Jason Hawkes, MD MS is a board-certified dermatologist in the greater Sacramento area. He received his medical degree and completed his dermatology residency training from the University of Utah School of Medicine, where he was also enrolled in the Program's 2+2 dermatology research track. Dr. Hawkes then worked as a medical dermatologist as a faculty member in the Departments of Dermatology at the University of Utah, Icahn School of Medicine at Mount Sinai, and University of California Davis. In addition to being a board-certified dermatologist, he completed a research fellowship in translation immunology at the National Institutes of Health (NIH) and received a master's degree in Clinical Investigation from Rockefeller University in NYC.   Dr. Hawkes is currently serving on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF), as well as his role as Councilor in the International Psoriasis Council (IPC). He is the recipient of multiple research grants and teaching awards, including the 2021 NPF Outstanding Educator in Psoriatic Disease. He has served as the Principal Investigator and Co-Investigator of multiple pharmaceutical-sponsored and investigator-initiated clinical trial protocols. He is the author of more than 60 peer-reviewed publications and 10 book chapters. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, and eczema, using novel systemic or biologic therapies.   To learn more about the Interaction of the Immune and Digestive Systems in the Context of Skin Disease, attend Dr. Hawkes' lecture at the 2023 Integrative Dermatology Symposium.

Is It Safe For People With Cancer To Eat Fruit And Beans? Dr. Thomas Seyfried, • Contact: thomas.seyfried@bc.edu • Book – Cancer as a Metabolic Disease #ThomasSeyfried#Cancer #MetabolicDisease Dr. Thomas Seyfried, is a professor and author publishing a groundbreaking book; Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer.This book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism.  However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited.  This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requiring metabolic solutions for its management and prevention.  Support for this position is derived from critical assessment of current cancer theories.  Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate. The book also provides extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet. Experts in the cancer research field have praised this comprehensive study as one of science's hottest topics. Dr. Thomas Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He has a Master's degree in Genetics from Illinois State University.  Thomas Seyfried served with distinction in the United States Army's during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society.  Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor.  Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).” To Contact Dr Thomas N. Seyfried, Ph.D. email:  thomas.seyfried@bc.edu Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Dr. Susan G. Friedman, Ph.D. is a professor emeritus in the Department of Psychology at Utah State University. Susan has co-authored chapters on behavior change in five veterinary texts, and her popular articles have been translated into 17 languages. She teaches seminars and courses on animal learning online (How Behavior Works: Living & Learning With Animals), with students from 63 countries so far. Susan also consults with zoos and animal organizations around the world. She was appointed to the F&WS California Condor Recovery Team from 2002 – 2010, after which time the team was retired due to the success of the birds in the wild. She is the Chairperson of the Scientific Advisory Committee of American Humane Association (AHA) Film and TV Unit, and a member in good standing of ABAI, ABMA, IAATE and IAABC. For links visit here >>> https://atamember.com/2023/05/08/function-assessments/

This week, we're in New York, attending the Pathways To Cures Global Summit. The National MS Society is convening the world -- bringing together the best and brightest minds in MS research, the CEOs of major MS Societies, representatives from the pharmaceutical industry and people affected by MS -- to update the scientific foundation of the Pathways To Cures research roadmap and set the global MS research agenda for the next 3-5 years. Don't miss next week's episode of RealTalk MS, when you'll hear from many of the experts on hand for this historic meeting. In this week's episode, we're talking about exacerbations, flares, attacks -- these are just some of the words we use when we're describing an MS relapse. Relapses impact over 85% of the people living with MS. And today, we're reviewing the things you need to know when it comes to MS relapses with Dr. Sam Hooshmand, the Director of the Multiple Sclerosis Clinic at the Milwaukee Veterans Affairs Medical Center, and Assistant Professor of Neurology at the Medical College of Wisconsin. We're also extending an invitation for you to spend a quick couple of minutes taking the RealTalk MS listener survey...and we're adding some motivation to that invitation by giving you an opportunity to win a $100 Amazon gift card. We'll introduce you to a remarkable MS research scientist and the Chair of the National MS Society's Scientific Advisory Committee, Dr. Tika Benveniste.  We're sharing the outcome of a study that compared the benefits of yoga and physical therapy for people living with MS. And we'll tell you about a first-of-its-kind collaboration between Cariloop and Walgreens that's designed to support MS caregivers. We have a lot to talk about! Are you ready for RealTalk MS??! Greetings from the Pathways to Cures Global Summit  :22 Take the RealTalk MS listener survey...you might win a $100 Amazon gift card!  2:09 This Week: Everything you should know about MS relapses  2:49 Meet the Chair of the National MS Society's Scientific Advisory Committee, Dr. Tika Benveniste   3:35 Study compares the benefits of yoga and physical therapy for people living with MS  16:53 Cariloop and Walgreens announce collaboration to support MS caregivers  21:19 Dr. Sam Hooshmand reviews everything you should know about MS relapses  24:13 Share this episode  34:09 Please remember to take our listener survey!  34:30 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/296 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Take the RealTalk MS Listener Survey  https://realtalkms.com/survey RealTalk MS Episode 125: From the Pathways To Cures Think Tank  https://realtalkms.com/125 RealTalk MS Episode 238: The Pathways To Cures Research Roadmap  https://realtalkms.com/238 RealTalk MS Special Podcast Series: Barancik Prize Conversations Part 1 https://realtalkms.com/barancik1 RealTalk MS Special Podcast Series: Barancik Prize Conversations Part 2 https://realtalkms.com/barancik2 STUDY: Yoga vs Physical Therapy in Multiple Sclerosis: Results of a Randomized Controlled Trial and the Training Protocol https://journals.sagepub.com/doi/full/10.1177/09727531231161994 Take the RealTalk MS Listener Survey  https://realtalkms.com/survey Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 296 Guests: Dr. Tika Benveniste and Dr. Sam Hooshmand Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS Privacy Policy

GBM And Other Stage 4 Cancers Should Not Be Considered Terminal If Treated With Ketogenic Metabolic Therapy Dr. Thomas Seyfried, • Contact: thomas.seyfried@bc.edu • Book – Cancer as a Metabolic Disease #ThomasSeyfried#Cancer #MetabolicDisease Dr. Thomas Seyfried, is a professor and author publishing a groundbreaking book; Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer.This book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism.  However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited.  This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requiring metabolic solutions for its management and prevention.  Support for this position is derived from critical assessment of current cancer theories.  Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate. The book also provides extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet. Experts in the cancer research field have praised this comprehensive study as one of science's hottest topics. Dr. Thomas Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He has a Master's degree in Genetics from Illinois State University.  Thomas Seyfried served with distinction in the United States Army's during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society.  Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor.  Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).” To Contact Dr Thomas N. Seyfried, Ph.D. email:  thomas.seyfried@bc.edu Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Rebecca Willis is a Professor in Energy & Climate Governance at Lancaster Environment Centre, where she leads the Climate Citizens  project. In 2020 she was an Expert Lead for Climate Assembly UK, the Citizens' Assembly established by the UK Parliament. Rebecca is a Trustee of the New Economics Foundation and an adviser to the National Lottery's Climate Action Fund. She features on the Woman's Hour Our Planet Power List which highlights 30 women making an impact by helping to protect our planet.  Her book, Too Hot To Handle? The democratic challenge of climate change was published by Bristol University Press in March 2020.Previously, she was a research fellow for the IGov project at the University of Exeter, investigating energy governance. From 2015-2019 she was a member of the Scientific Advisory Committee of UKRI's Energy Programme, and from 2011-15 she was a Council Member of the Natural Environment Research Council. She was Vice-Chair of the UK Sustainable Development Commission, advising the Prime Minister and First Ministers of the devolved administrations, from 2004-2011.  In 2009 Rebecca founded Green Alliance's Climate Leadership Programme, an initiative to support Members of the UK Parliament, and earlier served as Green Alliance's Director.

A Novel Therapeutic Strategy For The Metabolic Management Of Cancer Dr. Thomas Seyfried, • Contact: thomas.seyfried@bc.edu • Book – Cancer as a Metabolic Disease #ThomasSeyfried#Cancer #MetabolicDisease Dr. Thomas Seyfried, is a professor and author publishing a groundbreaking book; Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer.This book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism.  However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited.  This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requiring metabolic solutions for its management and prevention.  Support for this position is derived from critical assessment of current cancer theories.  Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate. The book also provides extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet. Experts in the cancer research field have praised this comprehensive study as one of science's hottest topics. Dr. Thomas Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He has a Master's degree in Genetics from Illinois State University.  Thomas Seyfried served with distinction in the United States Army's during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society.  Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor.  Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).” To Contact Dr Thomas N. Seyfried, Ph.D. email:  thomas.seyfried@bc.edu Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

If We Target Glucose And Glutamine We Can Manage The Majority Of Cancers Dr. Thomas Seyfried, • Contact: thomas.seyfried@bc.edu • Book – Cancer as a Metabolic Disease #ThomasSeyfried#Cancer #MetabolicDisease Dr. Thomas Seyfried, is a professor and author publishing a groundbreaking book; Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer.This book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism.  However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited.  This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requiring metabolic solutions for its management and prevention.  Support for this position is derived from critical assessment of current cancer theories.  Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate. The book also provides extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet. Experts in the cancer research field have praised this comprehensive study as one of science's hottest topics. Dr. Thomas Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He has a Master's degree in Genetics from Illinois State University.  Thomas Seyfried served with distinction in the United States Army's during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society.  Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor.  Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).” To Contact Dr Thomas N. Seyfried, Ph.D. email:  thomas.seyfried@bc.edu Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

The terms osteoporosis and osteoarthritis are often mistakenly used interchangeably as they are two separate diagnoses. Dr. Heather McDonald-Blumer, a rheumatologist is a member of the Division of Rheumatology at Mt. Sinai Hospital/University Health Network. Her clinical interests include osteoporosis and inflammatory joint disease. She is the associate director of the Osteoporosis Program at UHN and is a member of Osteoporosis Canada's Scientific Advisory Committee. On this episode, Dr. McDonald-Blumer discusses each condition, what makes them similar, how you can manage both conditions and more.

I'm excited to sit down with Dr. Thomas Seyfried. We talk about cancer, metabolic therapy, and much more. Make sure to listen to the full interview to learn more.Dr. Thomas N. Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He also holds a Master's degree in Genetics from Illinois State University. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology.Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor.We discuss the following:All about Dr. Thomas SeyfriedWhat is cancer?Warburg studyBest ways to protect ourselves from cancerGlucose and glutamineMetabolic therapy for cancer patientsZero carb diet and cancerThoughts on breast and ovarian cancer genesCancer and environmentThoughts on a carnivore diet for cancerTips to cancer patientsWhere to find Dr. Thomas Seyfried_____RESOURCESPubMed studies: https://pubmed.ncbi.nlm.nih.gov/?term=Seyfried+TN&cauthor_id=23237552 Foundation for metabolic cancer therapies: https://foundationformetaboliccancertherapies.com/ ____CHECK OUT MY BOOK, Carnivore CureSIGN UP FOR MY WEEKLY NEWSLETTER_____ ADDITIONAL RESOURCESNutrition with Judy ArticlesNutrition with Judy ResourcesCutting Against the Grain Podcast_____ FIND ME

Evidence That Challenges The Somatic Mutation Theory Of Cancer Dr. Thomas Seyfried, • Contact: thomas.seyfried@bc.edu • Book – Cancer as a Metabolic Disease #ThomasSeyfried#Cancer #MetabolicDisease Dr. Thomas Seyfried, is a professor and author publishing a groundbreaking book; Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer.This book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism.  However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited.  This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requiring metabolic solutions for its management and prevention.  Support for this position is derived from critical assessment of current cancer theories.  Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate. The book also provides extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet. Experts in the cancer research field have praised this comprehensive study as one of science's hottest topics. Dr. Thomas Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He has a Master's degree in Genetics from Illinois State University.  Thomas Seyfried served with distinction in the United States Army's during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society.  Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor.  Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).” To Contact Dr Thomas N. Seyfried, Ph.D. email:  thomas.seyfried@bc.edu Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Mitochondrial Respiratory Damage Is The Origin Of Cancer Dr. Thomas Seyfried, • Contact: thomas.seyfried@bc.edu • Book – Cancer as a Metabolic Disease #ThomasSeyfried#Cancer #MetabolicDisease Dr. Thomas Seyfried, is a professor and author publishing a groundbreaking book; Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer.This book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism.  However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited.  This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requiring metabolic solutions for its management and prevention.  Support for this position is derived from critical assessment of current cancer theories.  Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate. The book also provides extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet. Experts in the cancer research field have praised this comprehensive study as one of science's hottest topics. Dr. Thomas Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He has a Master's degree in Genetics from Illinois State University.  Thomas Seyfried served with distinction in the United States Army's during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society.  Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor.  Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).” To Contact Dr Thomas N. Seyfried, Ph.D. email:  thomas.seyfried@bc.edu Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

What are the current risks to our national and global food security? How do cyber-attacks play a role? What are the conflicts in the grain industry that prevent us from moving forward? Dr. Molly Jahn and Col. John Hoffman, two of the most sought-after food security experts in the world, provide their recommendations for real solutions to this growing problem.  About the guests: Dr. Molly Jahn is a professor at the University of Wisconsin-Madison where she holds appointments in the Department of Agronomy, the Nelson Institute, and the Global Health Institute. She is currently on an interagency personnel agreement from UW-Madison to work as a program manager at the Defense Advanced Research Projects Agency (DARPA). She is also appointed Joint Faculty at the US Department of Energy Oak Ridge National Laboratory (ORNL) where she chairs the Scientific Advisory Committee of the Energy and Environmental Sciences Directorate and sits on the Lab Director's SAC.  Col. John T. Hoffman is a senior research fellow with the Food Protection and Defense Institute (FPDI), a U.S. Department of Homeland Security Center of Excellence at the University of Minnesota. Col. Hoffman has extensive experience in developing, operating, hardening and sustaining extensive cyber systems.  Episode topics: Current global food security measuresImplications of cyber threats on food securityCyber-attack preparedness and current limitationsAction steps for the grain industryTo find more helpful resources, be sure to visit the GEAPS website and the membership page.   Grain Elevator and Processing Society champions, connects and serves the global grain industry and its members. Be sure to visit GEAPS' website to learn how you can grow your network, support your personal professional development, and advance your career. Thank you for listening to another episode of GEAPS' Whole Grain podcast.

New 2022 - Cancer As A Metabolic Disease: Implications For Novel Therapeutics - Thomas N. Seyfried, PhD Dr. Thomas Seyfried, • Contact: thomas.seyfried@bc.edu • Book – Cancer as a Metabolic Disease #ThomasSeyfried#Cancer #MetabolicDisease Dr. Thomas Seyfried, is a professor and author publishing a groundbreaking book; Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer.This book addresses controversies related to the origins of cancer and provides solutions to cancer management and prevention. It expands upon Otto Warburg's well-known theory that all cancer is a disease of energy metabolism.  However, Warburg did not link his theory to the "hallmarks of cancer" and thus his theory was discredited. This book aims to provide evidence, through case studies, that cancer is primarily a metabolic disease requiring metabolic solutions for its management and prevention.  Support for this position is derived from critical assessment of current cancer theories.  Brain cancer case studies are presented as a proof of principle for metabolic solutions to disease management, but similarities are drawn to other types of cancer, including breast and colon, due to the same cellular mutations that they demonstrate.The book also provides extensive information showing that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet. Experts in the cancer research field have praised this comprehensive study as one of science's hottest topics. Dr. Thomas Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He has a Master's degree in Genetics from Illinois State University. Thomas Seyfried served with distinction in the United States Army's during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society. Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor. Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).”To Contact Dr Thomas N. Seyfried, Ph.D. email:  thomas.seyfried@bc.edu CLICK HERE - To Checkout Our MEMBERSHIP CLUB: http://www.realtruthtalks.com  • Social Media ChannelsFacebook: https://www.facebook.com/TRTAHConferenceInstagram : https://www.instagram.com/therealtruthabouthealth/ Twitter: https://twitter.com/RTAHealth Linkedin: https://www.linkedin.com/company/the-real-truth-about-health-conference/ Youtube: https://www.youtube.com/c/TheRealTruthAboutHealth    • Check out our Podcasts  Visit us on Apple Podcast and Itunes search:  The Real Truth About Health Free 17 Day Live Online Conference Podcast Amazon: https://music.amazon.com/podcasts/23a037be-99dd-4099-b9e0-1cad50774b5a/real-truth-about-health-live-online-conference-podcastSpotify: https://open.spotify.com/show/0RZbS2BafJIEzHYyThm83J Google:https://www.google.com/podcasts?feed=aHR0cHM6Ly9mZWVkcy5zaW1wbGVjYXN0LmNvbS8yM0ZqRWNTMg%3D%3DStitcher: https://www.stitcher.com/podcast/real-truth-about-health-live-online-conference-podcastAudacy: https://go.audacy.com/partner-podcast-listen-real-truth-about-health-live-online-conference-podcastiHeartRadio: https://www.iheart.com/podcast/269-real-truth-about-health-li-85932821/ Deezer: https://www.deezer.com/us/show/2867272 Reason: https://reason.fm/podcast/real-truth-about-health-live-online-conference-podcast • Other Video ChannelsYoutube:https://www.youtube.com/c/TheRealTruthAboutHealthVimeo:https://vimeo.com/channels/1733189Rumble:  https://rumble.com/c/c-1111513 Facebook:https://www.facebook.com/TRTAHConference/videos/?ref=page_internal DailyMotion: https://www.dailymotion.com/TheRealTruthAboutHealth BitChute:  https://www.bitchute.com/channel/JQryXTPDOMih/ Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

Dr Aseem Malhotra is an NHS Trained Consultant Cardiologist, and visiting Professor of Evidence Based Medicine, Bahiana School of Medicine and Public Health, Salvador, Brazil. He is a world renowned expert in the prevention, diagnosis and management of heart disease. He is honorary council member to the Metabolic Psychiatry Clinic at Stanford University school of medicine California, and is Cardiology MSc examiner at the University of Hertfordshire, UK. He is a founding member of Action on Sugar and was the lead campaigner highlighting the harm caused by excess sugar consumption in the United Kingdom, particularly its role in type 2 diabetes and obesity. FIND OUT MORE ABOUT DR MALHOTRA AT: Board of Trustees https://phcuk.org/trustees/ Scientific Advisory Committee https://phcuk.org/sac/ PHC bio https://phcuk.org/members/dr-aseem-malhotra/ Website https://doctoraseem.com/ Social Media: Twitter @draseemmalhotra IG @lifestylemedicinedoctor FB Aseem Malhotra Patreon Dr Aseem   SPONSORS: X3 bar system with discount code "DRCHAFFEE" https://www.kqzyfj.com/click-100676052-13511487 THE CARNIVORE BAR: Discount Code "Anthony" for 10% off all orders! https://the-carnivore-bar.myshopify.com/?sca_ref=1743809.v3IrTuyDIi CARNIVORE CRISPS: Discount Code "DRCHAFFEEMD" for 10% off all orders! www.carnivorecrisps.com Shop Amazon https://www.amazon.com/shop/anthonychaffeemd?ref=ac_inf_hm_vp FOLLOW AND CONTACT ME: PATREON for early releases, bonus content, and weekly Zoom meetings https://www.patreon.com/AnthonyChaffeeMD Sign up for our 30-day carnivore challenge and group here! https://www.howtocarnivore.com/ INSTAGRAM: @anthonychaffeemd www.instagram.com/anthonychaffeemd/ TWITTER: @Anthony_Chaffee TIKTOK: @AnthonyChaffeeMD Apple Podcast: The Plant Free MD https://podcasts.apple.com/au/podcast/the-plant-free-md-podcast/id1614546790 Spotify: The Plant Free MD https://open.spotify.com/show/0WQtoPLuPMWWm3ZT3DYXzp?si=PPc2rXZzQXuzjIRK__SEZQ For Consults or collaborations, please email me at the below address. Please understand that I can not give advice over email, but only in a consultation setting: AnthonyChaffee@gmail.com For more of my interviews and discussions, as well as other resources, go to my Linktree at: https://linktr.ee/DrChaffeeMD OR my website at: www.TheCarnivoreLife.com And please like and subscribe to my podcast here and Apple/Google podcasts, as well as my YouTube Channel to get updates on all new content! Music track: Acoustic Breeze from Bensound.com #keto #fyp #cholesterol #carnivore #carnivorediet #weightloss #thecarnivorelife #weightsandsteaks #teamcarnivore #meatheals #yestomeat #nutrition #diet #autoimmune #rugby #rugbyunion #rugbyplayer #weightlossjourney #weightlifting #steak #bodybuilding #strength #strengthtraining #weighttraining #zerocarb  #ketovore #ribeye #liondiet #ketodiet #carnivoreketo #ketotransformation #carnivore75hard #vegan #sowell #thomassowell #dairy #milk #cheese #nsng #lchf #lcif

Professor Thomas Seyfried has published over 150 peer reviewed studies in biology and cancer biology and has verified Nobel Prize Winner Otto Warburg's assertation that cancer is a metabolic disease of the mitochondria, not a genetic disorder. If we misunderstand the origin of the disease, the treatment is going to be wrong as well, and this is exactly what has happened. Ever think about why the cancer rates have tripled in the past 40 years? Well, this is why. Thomas N. Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He also holds a Master's degree in Genetics from Illinois State University. Thomas Seyfried served with distinction in the United States Army's First Cavalry Division during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, the Ketogenic Diet Special Interest Group of the American Epilepsy Society, the Academy of Comprehensive and Complementary Medicine, and the American College of Nutrition. Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor. Dr. Seyfried is also the author of the book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley, 1st ed., 2012).   FOLLOW PROFESSOR SEYFRIED: Instagram: https://www.instagram.com/thomasseyfriedbc/   FOLLOW AND CONTACT ME AT: MY PATREON https://www.patreon.com/AnthonyChaffeeMD Sign up for our 30-day carnivore challenge and group here! https://www.howtocarnivore.com/ ORDER THE CARNIVORE BAR! Discount Code "Anthony" for 10% off all orders! https://the-carnivore-bar.myshopify.com/?sca_ref=1743809.v3IrTuyDIi ORDER CARNIVORE CRISPS! Discount Code "DRCHAFFEEMD" for 10% off all orders! www.carnivorecrisps.com For Consults or collaborations, please email me at: AnthonyChaffee@gmail.com Shop Amazon https://www.amazon.com/shop/anthonychaffeemd?ref=ac_inf_hm_vp INSTAGRAM: @anthonychaffeemd www.instagram.com/anthonychaffeemd/ TWITTER: @Anthony_Chaffee TIKTOK: @AnthonyChaffeeMD Facebook Group: The Carnivore Fix https://www.facebook.com/groups/1078241659422805 Weekly Q&A sessions: https://www.patreon.com/thecarnivorelife For more of my interviews and discussions, as well as other resources, go to my Linktree at: https://linktr.ee/DrChaffeeMD OR my website at: www.TheCarnivoreLife.com And please like, comment, share, and subscribe to my podcast here and Apple/Google/Spotify podcasts, as well as my YouTube Channel to get updates on all new content, and please give a 5-star rating! Music track: Acoustic Breeze from Bensound.com   RESOURCES: Professor Thomas Seyfried cancer as a metabolic disease https://youtu.be/06e-PwhmSq8 Ketogenic diets and cancer treatment https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375425/ Cancer Treatment With the Ketogenic Diet: A Systematic Review and Meta-analysis of Animal Studies https://www.frontiersin.org/articles/10.3389/fnut.2021.594408/full Carnivore cancer treatment center, Hungary https://humanperformanceoutliers.libsyn.com/episode-84-dr-zsofia-clemens Keto as cancer treatment and prevention https://youtu.be/DlI6DMZxgBY Dr Thomas Seyfried Cancer, mitochondria, and ketogenic diet and fasting in cancer treatment https://youtu.be/PuG5XZSR4vs Keto and glutamine, GBM treatment Seyfried https://www.nature.com/articles/s42003-019-0455-x Cancer causing polyunsaturated fat (Mitochondria effect) https://www.sciencedirect.com/science/article/pii/S2213231714001359 Red meat doesn't increase risk of colon cancer or all cause mortality https://www.mdpi.com/2072-6643/13/1/32   #carnivore #keto #weightloss #thecarnivorelife #carnivorediet #weightsandsteaks #teamcarnivore #meatheals #yestomeat #nutrition #diet #autoimmune #rugby #rugbyunion #rugbyplayer #weightlossjourney #weightlifting #steak #bodybuilding #strength #strengthtraining #weighttraining #zerocarb #ketovore #ribeye #liondiet #ketodiet #carnivoreketo #ketotransformation #carnivore75hard #vegan #sowell #thomassowell #dairy #milk #cheese #nsng #lchf #lcif

This episode of the Nick Bryant podcast features Dr. Michael Salter, the Scientia Associate Professor in Criminology at the University of New South Wales, Australia. He specializes in the study of organized sexual abuse and its treatment. Dr. Salter is on the Scientific Advisory Committee and the Board of Directors of the International Society for the Study of Trauma and Dissociation.   nickbryantnyc.com patreon.com/thenickbryantpodcast

Susan G. Friedman, Ph.D. is a professor emeritus in the Department of Psychology at Utah State University. Susan has co-authored chapters on behavior change in five veterinary texts, and her popular articles have been translated into 17 languages. She teaches seminars and courses on animal learning online (How Behavior Works: Living & Learning With Animals), with students from 60 countries so far. Susan also consults with zoos and animal organizations around the world. Susan was appointed to the F&WS California Condor Recovery Team from 2002 – 2010, after which time the team was retired due to the success of the birds in the wild. She is the Chairperson of the Scientific Advisory Committee of American Humane Association (AHA) Film and TV Unit, and a member in good standing of ABAI, ABMA, IAATE and IAABC. Website: www.behaviorworks.org Facebook: www.facebook.com/behaviorworks If you want to work with me, Susan Light, you can find me at: www.doggydojopodcast.com The music was written by Mac Light, you can find him at: www.maclightsongwriter.com If you like the show, please Subscribe, Rate, Review, and Share to help others find the show! I'll see you in two weeks with a brand new episode of the Doggy Dojo!

The Pathways to Cures initiative is focused on stopping MS progression, restoring lost function, and ending MS forever. This bold initiative has already been endorsed by more than 20 MS research and patient organizations around the world. And now, the publication of the Pathways to Cures Research Roadmap has brought us to a pivotal moment in the history of MS research. Joining me in this episode of RealTalk MS are two very special guests, Dr. Carol Whitacre and Professor Alan Thompson. We're taking a close look at what Pathways to Cures is all about, where we are on the Pathways to Cures Research Roadmap, and what this initiative means for people affected by MS. Dr. Whitacre is the former Senior Vice-President of Research at The Ohio State University, and the current Chair of the National MS Society's Scientific Advisory Committee. Professor Thompson is a clinician scientist who has been the recipient of virtually every high honor and award that's given in the field of multiple sclerosis research, including the John Dystel Prize for MS Research in 2017, the Sobek Research Prize in 2020, and the 2021 Charcot Award, which recognizes a lifetime of achievement in outstanding research into understanding and treating MS. We have a lot to talk about! Are you ready for RealTalk MS??! The Pathways to Cures Research Roadmap  :22 Dr. Carol Whitacre discusses the significance of the Pathways to Cures initiative  3:34 Prof. Alan Thompson reviews the status of MS research to stop progression, restore lost function, and end MS, then looks ahead to next steps in the Pathways to Cures research roadmap    16:14 Share this episode  33:52 Have you downloaded the RealTalk MS app?   34:12 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/238 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jonstrum@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com National MS Society COVID-19 Vaccine Guidance for People Living with MS https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance RealTalk MS Episode 125: The Pathways to Cures Think Tank  https://realtalkms.com/125 Pathways to Cures https://pathwaystocures.org Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 238 Guests: Dr. Carol Whitacre and Prof. Alan Thompson Tags: MS, MSAwareness MultipleSclerosis, MSResearch, MSSociety, RealTalkMS Privacy Policy

(Note: Recorded 1/19/22. Information that was correct and relevant at the time may be outdated.)   Susan H. Wootton, MD | McGovern Medical School Physicians Mom's Group Ask Lisa: The Psychology of Parenting on Apple Podcasts https://podcasts.apple.com/us/podcast/a-bit-of-optimism/id1515385282 Three Steps https://anewamericanwe.com/accelerating-a-paradigm-shift-towards-interbeing/ Your Local Epidemiologist Vaccine Education Center | Children's Hospital of Philadelphia   How is Covid affecting families, especially working moms in healthcare who can't do their jobs remotely?   In this anxiety-filled time, there's so much we cannot control. What we can do is connect to ourselves and connect to each other.   Rather than more Covid data which is readily available, we want to provide a different conversation today, steeped in hope and real social strategies for both work and home in terms of navigating it all.    Dr. Wooton focuses on the hope that we will get through this together, shares her own personal challenges, and highlights steps to make it through each long day, including personal experience in navigating everything from birthday parties to family reunions.    Doctor moms with kids under 5 and how stressful Covid has been to not be able to work from home/ all the pivoting it has required Strategies to stay sane and avoid burnout in the process: exercise, sleep, nutrition, asking for help Future outlook: historical knowledge and confidence that by definition, pandemics end at some point. Navigating invitations to gather with unvaccinated friends and family   As the Co-Chair of the Women Faculty Forum, she also shares helpful advocacy resources for moms in medicine.   Dr. Susan Wootton is a professor in Pediatric Infectious Diseases and member of the Center for Clinical Research and Evidence Based Medicine at the McGovern Medical School at UTHealth.  She graduated from Washington and Lee University with a B.A. in Mathematics, the Medical College of Georgia and then completed her pediatric residency at the University of Virginia.  She served as an Epidemic Intelligence Officer with the Centers for Disease Control and Prevention after which time she completed her pediatric infectious disease fellowship at Texas Children's Hospital and post-doctoral fellowship in Vaccinology at the University of British Columbia's Vaccine Evaluation Center in Vancouver, B.C.  Since joining the McGovern Medical School in 2007,  Dr. Wootton has been involved in all levels of teaching, clinical care and has received multiple clinical research awards.  Her research focuses primarily on vaccine-preventable infections and vaccine delivery.  She serves on the Texas Pediatric Society Infectious Disease Committee, The Immunization Partnership's Scientific Advisory Committee, and the Pediatric Infectious Disease Society's Vaccine Advocacy Committee.

Thomas N. Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He also holds a Master's degree in Genetics from Illinois State University. Thomas Seyfried served with distinction in the United States Army's First Cavalry Division during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honours have come from such diverse organisations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, the Ketogenic Diet Special Interest Group of the American Epilepsy Society, the Academy of Comprehensive and Complementary Medicine, and the American College of Nutrition. Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor. Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley, 1st ed., 2012). Find him on Twitter: https://twitter.com/tnseyfried or YouTube:https://www.youtube.com/channel/UC3usB3s0qqOo4wImv3fgf5A/featured This episode is hosted by Dr. Shawn Baker MD. Find him at https://shawn-baker.com Donate to the Carnivore Diet Clinical Trial: https://gofundme.com/f/carnivore-research